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Abstract 
This survey study investigated attitudes and practices of 161 licensed psychologists from 
a nationwide sample, relative to addressing negative effects of psychotherapy during the 
informed consent process.  Results revealed discrepancies in attitudes toward risk of 
negative treatment effects in psychotherapy and in addressing risk during the process of 
informed consent.  Information obtained from this study may contribute to research in the 
area of clinical implementation of the American Psychological Association’s Code of 
Ethics.  Implications for clinical practice are discussed.  Limitations of the study and 
directions for future research are also addressed.    
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 Chapter One: Introduction 
Statement of the Problem 
 Psychotherapy has the potential to produce a plethora of positive and negative 
effects.  Lilienfeld (2007) listed several of these potentially negative effects of 
psychotherapy, including “symptom worsening, the appearance of new symptoms, 
heightened concern regarding existing symptoms, excessive dependency on therapists, 
reluctance to seek future treatment (Boisvert & Faust, 2003), and even physical harm,” 
(Mercer, Sarner, & Rosa, 2003, p.56).  Research suggests that a significant minority of 
clients experience negative effects, including iatrogenic and/or deterioration effects as a 
result of psychotherapy (Boisvert & Faust, 2002).  Data suggest a failure rate that 
approaches one-third, and a rate of deterioration, with estimates ranging from 3 to 10 
percent (Bergin, 1971; Strupp, Hadley, & Gomes-Schwartz, 1977; Mohr, 1995; Stricker, 
1995; Lambert & Ogles, 2004; Lilienfeld, 2007).  Estimates of client deterioration are 
higher in the substance abuse literature, averaging about 10 to 15 percent (Ilgen & Moos, 
2005; Moos, 2005).  Among group psychotherapy, Leiberman and Yalom (1973) reveal 
“a negative change figure of 16 percent that include 8 percent casualties,” in which 
casualties were defined as “an enduring (8 months or more), significant negative 
outcome, which was caused by [an individual's] participation in the group” (as cited in 
Roback, 2000, p. 1).  A survey study of negative outcome published in 1981 (Buckley, 
Karasu, & Charles) revealed that 21 percent of mental health professionals endorsed 
harmful outcomes as a result of engaging in their own personal psychotherapy.  In a 
review of two meta-analyses, Mohr (1995) found 9 to 13 percent of studies produced 
negative effect sizes for psychotherapy outcome in the negative direction (Smith, Glass, 
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& Miller, 1980; Shapiro & Shapiro, 1982), suggesting negative effects as a result of 
therapy.  Results from an international survey of 12 leading psychotherapy outcome 
researchers concluded that “approximately 10 percent of clients get worse as a result of 
therapy” (Boisvert & Faust, 2003, p. 512).  Considering the number of individuals who 
engage in psychotherapy every year, this is not an insignificant statistic (Olfson, Marcus, 
Druss, & Pincus, 2002).  
 The idea that psychotherapy has the latent ability to produce negative effects has 
potential implications for informed consent.  Due to the multidimensionality of 
potentially negative effects of psychotherapy, assessing psychologists' attitudes regarding 
risk toward iatrogenic and deterioration effects may be an important indicator of what is 
considered material to a client's decision during the informed consent process.  Informing 
clients about the potential risks and benefits of psychotherapy is a fundamental 
component of obtaining informed consent, analogous to a physician’s informing a patient 
about the risks and benefits of medication or treatment.  
 The current American Psychological Association's (APA) Ethical Principles of 
Psychologists and Code of Conduct (2002), (hereinafter, Ethics Code) include broad 
guidelines regarding the process of obtaining informed consent to therapy.  Ethical 
standard 10.01b states that for some treatments it is also necessary to “inform 
clients/patients of the developing nature of the treatment, the potential risks involved, 
[and] alternative treatments that may be available” (APA, 2002, p. 1072).  Although 
“particularly stringent consent procedures,” Barden (2001) notes, “should apply to 
'treatments' lacking rigorous, empirical evidence of safety and efficacy,” all forms of 
psychotherapy “irrefutably fall within the scope of patient's rights to informed consent” 
INFORMED CONSENT IN PSYCHOTHERAPY 3 
(p. 160).  Psychologists are also ethically obligated to obtain informed consent to 
psychotherapy “as early as feasible” (APA, 2002, p. 1072).  It is consistent with the 
fundamental concepts of informed consent to discuss with prospective clients that therapy 
may not work for them and that there is a risk, although somewhat small, of negative 
effects when engaging in psychotherapy (Boisvert & Faust, 2003; APA, 2002).  Risks are 
thought to be material when a reasonable person in the client’s position, “would likely 
attach significance to the risk or cluster of risks in question in deciding whether or not to 
forgo the proposed therapy (Canterbury v. Spence, 1972, p. 787)” (as cited in Noll, 1981, 
p. 915).  To neglect potential risk of negative effects during the informed consent process 
imposes serious ethical and moral questions (Noll, 1981).  There is no “normative data 
for what a reasonable person understands in various consent situations (e.g., high versus 
low risk with high versus low individual benefit)” (Tymchuk, 1997, p. 58).  Although 
psychologists might occasionally discuss potential negative effects of psychotherapy 
(e.g., on an as-needed basis) during the informed consent process, they may not be aware 
of the extent to which this phenomenon exists.  Common finding among psychotherapy 
outcome studies reveal negative responders tend to be embedded in the outcome variance 
or appear simply not to be reported (Mohr, 1995; Dishion, McCord, & Poulin, 1999).  
The field of psychotherapy has tended to avoid examining negative outcomes by not 
reporting them, which Mohr (1995) suggest is problematic and limits the overall potential 
for the psychological profession.  As a result, the lack of accurate information from 
research, related to negative effects of psychotherapy, may contribute to psychologists’ 
currently held attitudes and beliefs.  Research findings suggest that there appears to be a 
similarity in the reported ethics and belief systems of psychotherapists and in their 
INFORMED CONSENT IN PSYCHOTHERAPY 4 
subsequent practices (Somberg, Stone, & Claiborn, 1993; Pope, Tabachnick, & Keith-
Spiegel, 1987).  Therefore, it is important to understand licensed psychologists’ current 
attitudes and practices regarding the informed consent process related to addressing risk 
of potential negative treatment effects of psychotherapy.  
Purpose of the Study 
 This study examined the general attitudes and practices of licensed psychologists 
relative to informing clients, during the informed consent process, of potentially negative 
effects of psychotherapy.  In order to better understand the current practices of addressing 
risk during informed consent, attention needs to be given to attitudes.  Although 
psychologists believe in the general application of informed consent (Somberg, Stone & 
Clairborn, 1993), little information is available about specific informed consent issues 
and practices.  For example, attitudes about the impact of consent procedures may impact 
a psychotherapist’s decision.  Attitudes related to addressing risk of negative treatment 
effects that are thought; to some degree to affect the therapeutic relationship negatively 
might change the implementation of informed consent practice (MacDevitt & Acker, 
1990).  Although there is no evidence, empirically, to support negative expectation 
(Handelsman, 1990) for informed consent practices, concerns may be present for 
practicing clinicians.  
 Information obtained from this survey study could be used to improve clinical 
guidelines and standards of disclosure for licensed practicing psychologists relating to the 
process of informed consent.  Demographic variables (e.g., age, gender, ethnicity, degree, 
primary theoretical therapeutic orientation, practice setting, years working as a licensed 
psychologist, primary population treated, primary therapeutic modality, American Board 
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of Professional Psychology (ABPP) certification, and post-doctoral training on ethics and 
informed consent) were examined in relation to licensed psychologists’ attitudes and 
practices related to addressing potentially negative effects of psychotherapy; in addition 
to this, the relationship between attitudes and practices was studied.  The method 
included a survey questionnaire which was developed by the researcher (see Appendix 
B).  The sample consisted of 161 currently licensed doctoral level psychologists from a 
nationwide population.  Information gathered by this study contributes to the sparse 
literature related to psychologists’ attitudes and practices toward addressing negative 
effects of psychotherapy during the informed consent process.  This study aids 
psychological, as well as other mental health professionals, gain a more thorough 
understanding of how the psychological profession implements the APA's Code of Ethics 
into psychotherapy practice and the process of informed consent.   
This study intended to answer several general research questions: 
1) Do licensed psychologists address, as part of a conversation of risks, potentially 
negative effects of psychotherapy during the informed consent process? 
2) What are licensed psychologists’ general attitudes and practices toward 
addressing risk of negative effects of psychotherapy during the informed consent 
process? 
3) What are licensed psychologists’ general attitudes toward APA’s ethical practices 
and implementation of informed consent procedures? 
4) What is the relationship between number of years of formal training as a licensed 
psychologist and subsequent attitudes and practices toward addressing risk related 
to negative effects of psychotherapy during the process of informed consent? 
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5) What is the relationship between licensed psychologists’ theoretical therapeutic 
orientations and attitudes and practices toward addressing negative effects of 
psychotherapy during informed consent? 
6) What is the relationship between licensed psychologists’ attitudes and practices 
toward therapeutic privilege related to addressing risk of negative effects of 
psychotherapy during the process of informed consent? 
7) What are licensed psychologists’ general attitudes and practices toward a 
discussion of alternative treatment and/or procedures during the informed consent 
process? 
Relevance to Cognitive Behavior Therapy 
 The application of ethical practices to psychotherapy is complex and there is 
minimal research to illustrate how psychologists generally implement informed consent. 
Although many professional psychologists view the informed consent process as a means 
of implementing ethical responsibility to their clients (e.g., Handelsman & Galvin, 1988; 
Hare-Mustin, Maracek, Kaplan, & Liss-Levinson, 1979; Noll & Haugan, 1985), there is 
limited explicit recognition or even limited discussion in the literature outlining the need 
to address risks including potentially negative effects of psychotherapy.  Ethical 
responsibility and the requirement of informed consent are derived from the principle of 
respect for individual autonomy (Faden & Beauchamp, 1986; Kitchener, 1984). 
According to this principle, an individual has the right to act as an informed free agent 
when making a decision (Kitchener, 1984).  In order to do so, however, the individual 
needs information that is relevant to making his or her decision.  Informed consent helps 
maintain an individual’s autonomy by ensuring that the individual has received relevant 
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information, regardless of whether or not he or she intends to use the newly acquired 
knowledge (Handelsman & Galvin, 1988).  
 Some therapeutic orientations may lend themselves, in a greater degree, toward 
encouraging autonomy in their clients.  Client autonomy, for example, is a fundamental 
aspect of Cognitive-Behavioral Therapy (CBT).  In their study, Somberg et al. (1993) 
revealed “therapists of a Cognitive-Behavioral orientation indicated they inform clients 
more often and consider the issues more important” than therapists from other therapeutic 
orientations (p. 153).  CBT includes a collaborative emphasis with active participation 
and a team-work approach, in which client and therapist decide together what to do in 
session and how often to meet (Beck, 1995).  The “shared decision making” approach, 
according to Knapp and VandeCreek (2006), reflects those “mutually agreed upon goals 
and intervention strategies” as part of the therapist-client collaboration during informed 
consent (p. 99).  With such a strong emphasis on the client’s taking an active role in 
treatment, it seems that psychologists whose primary orientation is CBT would be more 
likely to encourage client participation and be more likely to inform clients of potential 
risks during the process of informed consent.   
Overview of Literature Review 
 Presented next is an overview of informed consent, including the various 
historical, ethical, religious, and legal influences that have shaped its process.  Following 
that, issues related to the application of informed consent, including the risks and benefits 
of negative treatment effects will be highlighted and discussed.  Careful considerations 
relative to addressing negative treatment effects as a result of psychotherapy are 
explored.  After that, the methodology used for the study and the results of the study are 
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presented and discussed. A discussion of the conclusions will be presented and explored. 
Finally, limitations of the survey study and directions for future research are addressed.    
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Chapter Two: Review of the Literature 
Defining Important Terms 
 Psychotherapy.  A classic definition of “psychotherapy” originally defined by 
Stoudemire (1998) and later articulated by Beahrs and Gutheil (2001), include the “use of 
interpersonal influence skills and psychological techniques by trained professionals 
toward the goal of relieving the signs and symptoms of psychiatric disorder” (p. 4). 
Psychotherapy is defined as a “procedure,” similar to that of a medical procedure (Beahrs 
& Gutheil, 2001).  Research concludes that psychotherapy be considered a well-proven, 
well-researched and effective tool, used to relieve both symptomatic psychic distress and 
other medical illnesses (Bloom, 1992; Sperry, Brill, Howard, & Grissom, 1996; Gabbard, 
Lazar, Hornberger, & Spiegel, 1997; Stevenson & Meares, 1992).  Despite its widespread 
use, psychotherapeutic treatment is ambiguous and adds to the complexity of defining 
potentially negative effects in psychotherapy.  The manner of delivery of a 
psychotherapeutic treatment can be both harmful and helpful and can be applied in a 
variety of ways, depending on the skill level of the psychologist and the context of the 
intervention.  Scientific texts, the legal system, and third-party payers have impacted the 
practice of psychotherapy and created significant legal implementations, similar to those 
found within the medical profession (Beahrs & Gutheil, 2001).  One of the most 
important of these constraints is the duty of mental health professionals to provide clients 
with informed consent.     
 Informed consent.  An overarching definition of “informed consent” according 
to Berg, Applelbaum, Lidz, and Parker (2001) includes:  
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Legal rules that prescribe behaviors for physicians and other health care 
professionals in their interactions with patients and provide penalties, under given 
circumstances, if physicians deviate from those expectations; to an ethical 
doctrine, rooted in our society's cherished value of autonomy, that promotes 
patients' right of self-determination regarding medical treatment; and to an 
interpersonal process whereby these parties interact with each other to select an 
appropriate course of medical care (p. 3).  
Because of the complexity of the term, for the purpose of this proposal, “informed 
consent” may be thought of, according to Simon (1992) and explicitly described by 
Beahrs & Gutheil (2001) as “a process of sharing information with patients that is 
essential to their ability to make rational choices [for psychotherapy] among multiple 
options in their perceived best interest” (p. 4).  As a prerequisite to engaging potential 
clients in psychotherapy, the Ethics Code (2002, Section 10) mandates a necessary 
informed consent discussion.  The ideal format according to Jensen, McNamara, and 
Gustafson (1991) for informed consent for psychotherapy must include a discussion 
between therapist and client of goals, methods, concomitant benefits and risks of 
psychotherapy, as well as possible alternatives to the proposed treatment. 
 Negative treatment effects.  There are issues in definition about how to label 
psychotherapy decline.  Originally defined by Strupp and Hadley (1976), the term 
“negative treatment effects” applied to “patients getting worse as a function of the 
therapeutic influence” (e.g., iatrogenic effects) as opposed to the term “negative 
outcome” which pertained to a decline in functioning regardless of the original cause(s) 
(e.g., deterioration effects) (Mays & Franks, 1985, p. 20).  Despite the researchers’ 
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classic definition, the term “negative effect” appears to be used interchangeably with 
“negative treatment effects” within the research literature.  For example, Mays and 
Franks (1985) suggested “negative effect” or “negative outcome” should be applied to 
patients who got worse, even when there appeared to be no evidence that individuals who 
became worse was a direct consequence of psychotherapy.  In their research, Dies and 
Teleska (1985), use “negative outcome” to imply that a patient was becoming worse in 
his or her overall functioning or symptomology, as a result of treatment.  Bergin (1963) 
used the term “deterioration effects” in his research to describe individuals who decline 
in psychotherapy, when there appeared to be greater variability in the experimental group 
than in the control group on criterion measures in psychotherapy.  In his review of 
psychotherapy research, Bergin (1963) noted there were a consistently larger proportion 
of individuals in the experimental groups whose symptoms improved and got worse, than 
in the comparison groups.  The judgment of causality, according to Lieberman et al. 
(1973), is based on the finding that an individual has “deteriorated in major adult role 
functioning” (as cited in Roback, 2000, p. 115).  Because of the variability in terminology 
among researchers and clinicians, it is difficult, if not almost impossible, to operationally 
define negative effects of psychotherapy.   
 The lack of consensus in existing literature related to what constitutes negative 
effects of psychotherapy reflects the conceptual complexities in this area.  One classic 
definition states that negative effects occur “when there is no meaningful positive change 
in a client due to some aspect of the treatment process” (Nolan, Strassel, Roback, & 
Binder, 2004, p. 311).  The most extreme negative effect is related to “client deterioration 
in functioning that is attributed to the course of therapy” (Nolan et al., 2004, p. 311). 
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Lilienfeld (2007) utilizes the term “psychological harm” as including “not only 
deterioration but also a decelerated rate of improvement that is a consequence of 
psychotherapy” or something that is attributable to the direct effects of psychotherapy (p. 
57).  Mohr (1995) describes both terms “potential negative effects for treatment” and 
“potential deterioration” interchangeably in his research (p. 189).  The five indicators for 
“potential deterioration,” as a result of interaction between therapeutic techniques, 
psychotherapists, and clients include, “(a) the role of anticipation of emotional pain and 
therapeutically induced arousal, (b) client suspiciousness toward the therapist and 
therapist empathy, (c) level of interpersonal functioning and the focus of treatment, (d) 
diagnosis and treatment modality, and (e) relaxation therapy and clients’ need for 
control” (Mohr, 1995, p. 187).  
 Negative treatment effect detection during the course of psychotherapy is 
similarly complex.  Clinical experience is often valued among psychologists as a method 
to assess treatment progression, including ways to proceed with the course of 
psychotherapy (Stewart and Chambless, 2007).  Research has demonstrated, through the 
use of empirical and actuarial models, correctly identifying risk for treatment failure are 
reliably superior to the use of clinical judgment (Kadden, Cooney, Getter, & Litt, 1989; 
Lutz, et al., 2006; Shulte, Kunzel, Pepping, & Shulte-Bahrenberg, 1992; Stewart and 
Chambless, 2007).   
 Because psychotherapy outcome is multidetermined, the question arises about 
which factors may potentially have the strongest influence on client outcome.  Results 
from research conclude client characteristics “are the most powerful determinants of 
outcome” (Sachs, 1983; Gomes-Schwartz, 1977).  However, it has also been noted by 
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Luborsky et al. (1980) that “patient characteristics only account for a small proportion of 
the variance” (as cited in Sachs, 1983, p. 558).  According to client-centered theorists, 
therapist factors are also considered important to overall psychotherapy outcome (Sachs, 
1983).  Although specific techniques do not seem to have a “differential effect on 
outcome”, personal characteristics of both the client and therapist appear to be the 
“strongest determinants of outcome” (Sachs, 1983, p. 558).  In a research study on 
characteristics of the therapeutic process (among psychodynamic and experiential 
therapy), and its relationship to negative outcome, Sachs (1983) revealed that factors 
shown to be highly related to client outcome were associated with the quality (or lack of 
quality) of a therapeutic technique.  
 From the time Sigmund Freud introduced the term “countertransference” (in 
1910), there have been insufficient cases in the research literature on “negative 
therapeutic reaction to describe patients who apparently fail to benefit from 
psychotherapy or get worse” (Mays & Franks, 1985, p. 21).  Although the psychoanalytic 
literature considers lack of successful treatment regarding both clients (e.g., Freud, 
1937/1964) and therapists being primarily related to “countertransference” (e.g., Gorkin, 
1987), other examples of failure cases are rare (Rogers, 1954; Stricker, 1995).  Strupp et 
al. (1977) conducted one of the most comprehensive reviews of negative effects of 
psychotherapy among experts in the field (researchers, clinicians, and theoreticians) from 
various theoretical orientations.  Nearly every one of the 70 prominent psychotherapists 
who responded to the survey by Strupp et al. (1977) agreed that psychotherapeutic 
negative effects were problematic and concluded “a worsening of a patient's condition 
attributable to his having undergone psychotherapy” (p. 91) was what these negative 
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effects entailed.  Strupp et al. (1977) discuss two kinds of negative effects as a result of 
psychotherapy, “those generally harmful to patient, and those harmful to the attainment 
of the goals of therapy which may or may not include harm to the patient” (as cited in 
Mays & Franks, 1985, p. 21).  Strupp et al. (1977) reveal that negative effects are 
associated with a variety of problems related to inaccurate assessment, patient or therapist 
qualities within the therapeutic relationship, and among techniques or treatment 
approaches.  It appears challenging in psychotherapy research to be able to separate 
iatrogenic effects from deterioration effects with significant confidence because there 
could be other factors within the psychotherapeutic process to account for the negative or 
adverse outcomes (Roback, 2000).  
Psychotherapy Failure versus Treatment That May Cause Harm 
Therapeutic failure (no clinical improvement).  Research is limited regarding 
decision practice to discontinue psychotherapy when clients fail to make progress.  The 
Ethics Code (2002) dictates that psychologists strive for beneficence and strive to do no 
harm; however, when psychologists continue to treat clients who appear to gain no 
benefit from psychotherapy, Stewart and Chambless (2008) note, “This practice in itself 
can be harmful” (p. 176).  In order to achieve clinically significant improvement, Hansen, 
Lambert, and Forman (2002) suggest treatment duration lasting from 13 to 18 sessions.  
In a recent study, Stewart and Chambless (2008) surveyed psychologists in independent 
practice (N=591) regarding treatment failures.  Psychologists reported that clients 
attended psychotherapy for a “median of 12 times before concluding no progress was 
being made” (p. 179).  Specifically, 36 percent of psychologists reported treating clients 
who were not improving for longer than 19 sessions, and 10 percent reported treating 
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those clients for longer than 30 sessions before “concluding failure” (p. 180). 
Psychologists rated “colleague consultation and clinical experience” as primary methods 
for termination decision, rather than empirical research (p. 179).  These researchers 
reported that psychologists’ theoretical orientation impacted the definition of failure and 
subsequent treatment decision.  Specifically, psychologists from a psychodynamic 
orientation tended to treat clients “significantly longer” than those from cognitive-
behavioral and/or eclectic orientations (p. 176).  Cognitive-behavioral and other eclectic 
clinicians tended to use “treatment materials informed by psychotherapy outcome 
research and refer patients to other clinicians” more often, than those from the 
psychoanalytic approach (p. 176).  In light of evidence-based practice, the tendency to 
rely on clinical experience alone rather than on empirical research to inform practice is 
inconsistent with current trends in outcome literature.  Therapeutic failure, according to 
Stewart and Chambless (2008), has both an immediate effect, leaving clients in an 
“unimproved or even deteriorating state” and the potential to change clients’ perceptions 
of “psychotherapy and make them subsequently less likely to pursue psychotherapeutic 
treatment” for their difficulties (p. 180).  There is a clear distinction between no clinical 
improvement and psychotherapy failure and a client’s becoming worse, as a result of 
harmful or negative treatment effects.  
Treatment that may cause harm.  There are methodological issues that 
complicate defining psychological harm operationally.  Research is limited, to date, that 
outlines how mental health professionals define client improvement or worsening as a 
result of engaging in psychotherapy.  Clients’ overall symptomology may improve over 
the course of treatment; however, use of an alternative (more effective) treatment may 
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have speeded up the process.  It could be argued that psychotherapy, in this regard, could 
be thought of as harmful because it took the client longer for his or her symptoms to 
dissipate.  It is difficult to know whether or not deterioration effects may have occurred 
without the intervention, or perhaps participation in treatment may have slowed down the 
deterioration process.  The potential of psychotherapy to cause harm can occur as a result 
of the psychotherapeutic treatment or decisions made about the treatment (Lilienfeld, 
2007).  Negative effects that result from harmful treatment are thought to have a causal 
effect because the outcomes produced are worse than if there were no treatment.  There 
are numerous instances of known psychotherapeutic treatments and techniques that have 
the potential to cause harm, including: critical incident stress debriefing, facilitated 
communication, recovered-memory techniques, boot camps for conduct disorder, 
attachment therapy, dissociative identity disorder-oriented psychotherapy, grief 
counseling for normal bereavement and expressive-experiential psychotherapies 
(Lilienfeld, 2007).  Potentially problematic psychological treatments, Lilienfeld (2007) 
notes, that have a tendency to produce both positive and negative effects, should be used 
with particular caution.  Although the prevalence of questionable psychotherapy practices 
is presently unknown, Lilienfeld (2007) indicates that research-oriented mental health 
professionals may underestimate how often and when they are utilized.  
 There is a current lack of consensus within the psychological field regarding 
harmful treatment detection and subsequent practices.  For the purpose of this study, it is 
noteworthy to make a distinction in definition because failure to provide appropriate 
treatment that could have improved a client’s symptomology is different from providing 
treatments that cause harm.  Related to this are psychological treatments and techniques 
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that are considered unhelpful (e.g., a client in treatment for depression who commits 
suicide).  The distinction lies between clients experiencing negative effects as a result of 
having a psychological disorder, and negative treatment effects as a result of engaging in 
potentially harmful treatment.  Although psychological disorders can cause a myriad of 
harmful negative effects, this study’s focus will be on harm that results from 
psychotherapeutic treatment application, not on harm embedded in the psychological 
disorder itself.  Whittington et al. (2004) assert that psychotherapeutic treatment has the 
potential to impact a disorder negatively and adversely impact other domains.  For 
example, the use of selective serotonin reuptake inhibitors (SSRI’s), as antidepressant 
medications with adolescents, has been associated both with improvement in depressive 
symptoms and with a potential to increase risk for suicide (ideation and attempt) 
(Whittington et al., 2004).  Data from empirically-based research suggest exposure 
therapy is thought to lead to increased levels of distress during implementation (an issue 
of concern for those who use this method of treatment with post-traumatic stress 
disorder) (Foa, Zoellner, Feeny, Hembree, & Alvarez-Conrad, 2002).  Nishith, Resick, 
and Griffin (2002) report a small minority of clients (who engaged in exposure therapy 
treatment) displayed reliable increases in general anxiety, and others experienced an 
exacerbation of post-traumatic stress disorder symptoms.  Similarly, Neimeyer (2002) 
suggested clinical concern regarding the use of grief therapy treatment and its potential to 
interfere with the normal process of recovery from loss, over time.  Addler, Craske, and 
Barlow (1987) suggested that the phenomenon of harmful effects may occur if such 
effects may be moderated by client characteristics.  Although relaxation techniques are 
INFORMED CONSENT IN PSYCHOTHERAPY 18 
beneficial to the majority of clients, they can also induce panic attacks among a small 
minority of individuals who engage in this form of psychotherapy treatment. 
 There are potential problems in not having a consensus of definition both in 
research and in practice.  An operational definition of potentially negative treatment 
effects (including treatment that does not work and may cause harm) from psychotherapy 
would aid in understanding the occurrence of these effects, including how they impact the 
client population.  It would also be beneficial to define these problematic effects so that 
practicing psychologists can address and articulate them during the informed consent 
process.  A lack of terminology consensus suggests that even experts struggle to discern 
trends in this area of psychotherapy research.  It appears unrealistic to expect 
psychologist practitioners to draw consistent conclusions about negative effects of 
psychotherapy from literature that does not necessarily lend itself to consistent 
conclusions.  
Informed Consent Underpinning 
 Informed consent is the process by which clients are informed of their rights 
regarding psychotherapeutic treatment, as well as the benefits and risks of treatment.  The 
foundation and justification of informed consent derive from various lines of reasoning 
including philosophy, religion, and the law.  
 Philosophical support.  The origin of informed consent, according to Levine 
(1995), is derived from the ancient Hippocratic directive “to help, or at least to do no 
harm” – in which the benefit for seeking information for the client “provides a 
mechanism for ascertaining what the patient would consider a benefit” (as cited in 
Emanuel, Crouch, Arras, Moreno, & Grady, 2003, p. 197).  Allowing an individual to 
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decide what is beneficial “is consistent with the perspective affirmed in U.S. public 
policy that competent persons are generally the best protectors of their own well-being” 
(as cited in Emanuel et al., 2003, p. 197).  However, ensuring adequate consent when 
potentially negative effects are of concern, appear more complex than acquiring consent 
when an individual might think that the effects would be beneficial.  The requirements 
for informed consent derive from the principle “respect for persons”, which according to 
Levine (1995) include two basic “ethical convictions” outlined by the U.S. National 
Commission for the Protection of Human Subjects of Biomedical Research (hereinafter, 
NCPHSBR), which ensure individuals be treated as “autonomous agents” with particular 
emphasis for protection of those individuals “with diminished autonomy... are entitled to 
such protection” (as cited in Emanuel et al., 2003, p. 197).  
 Religious support.  The Judaeo-Christian tradition is another origin for the 
requirement of seeking consent.  Levine (1995) notes the requirement for consent “is 
grounded explicitly in the notion of covenant”, and that seeking adequate consent “is an 
affirmation of the basic faithfulness of care required by the fundamental covenantal 
nature of human existence” (as cited in Emanuel et al., 2003, p. 197).  The notion that 
human life is a “gift from God and is of infinite and immeasurable worth (the 'sanctity of 
life')” reflects the religious understanding of how individuals should act toward each 
other “with respect and not interfere in each other's lives without consent” (as cited in 
Emanuel et al., 2003, p. 197). 
 Legal support.  Informed consent in the legal context was clarified in by a 1914 
New York Supreme Court decision.  As part of a response to a medical malpractice suit, 
Justice Benjamin Cardozo asserted “every human being of adult years and sound mind 
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has a right to determine what shall be done with his own body” (Schloendorff v. Society 
of NY Hospital, 1914).  It is from this principle of “bodily integrity” Levine (1995) notes 
that the modern idea of informed consent grew within the medical profession.  An 
individual has the right to chose what is done to him or her, and no physician has the 
right to touch a patient without the person’s explicit consent.  Failure to obtain adequate 
informed consent, according to Levine (1995), could result in a charge of battery or 
negligence for which the plaintiff may claim damages and receive financial compensation 
(Emanuel et al., 2003).  The main purpose of the informed consent requirement, 
according to Levine (1995), is not necessarily to lessen the occurrence of risk or harm 
resulting from treatment, but to give an individual the option to chose whether or not to 
participate (Emanuel et al., 2003).  
 Although the legal basis for an informed consent requirement arose as a result of 
medical practice litigation, Levine (1995) asserts that there is currently no case law 
related to “legal standards for consent to research, as distinguished from practice” (as 
cited in Emanuel et al., 2003, p. 197).  If informed consent was not adequately obtained, 
Levine (1995) notes, it “was traditionally considered as a battery action [where] the law 
of battery makes it wrong, a priori to touch, treat, or do research upon a person without 
the persons consent” (as cited in Emanuel et al., 2003, p. 198).  In recent years, however, 
malpractice litigation tends to view obtaining insufficient informed consent as “as 
negligence rather than battery actions” (as cited in Emanuel et al., 2003, p. 198).  
Similarly, in order to “bring a negligence action, a patient/subject must prove that the 
physician had a duty toward the patient; that the duty was breached; and that the damage 
was caused by the breach” (as cited in Emanuel et al., 2003, p. 198).  According to the 
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law, if any information is withheld from the potential patients/clients that would have 
been pertinent to their decision to give informed consent, it is considered invalid under 
both the battery and negligence doctrines (Emanuel et al., 2003). 
Informed Consent Historical Factors 
 The concept of informed consent has distant roots in medical ethical principles of 
beneficence, doing no harm, and helping patients (Faden & Beauchamp, 1986; Chadwick 
& Mann, 1978).  Obtaining patient/client involvement in treatment decisions is somewhat 
contemporary and has become a more stringent requirement in recent years (Walker, 
Logan, Clark, & Leukefeld, 2005; Manning & Gaul, 1997).  What once was considered 
good patient overall care, when physicians tended to act on their own authority without 
informing patients about important treatment decisions, has dramatically changed (Katz, 
1999).  The previous paternalistic viewpoint tended to focus on whether or not patients 
would be able to understand or comprehend the information presented to them, which 
subsequently led to inadequate information obtained about treatment (Katz, 1999).  The 
first evidence of informed consent as a major issue in American medicine was in the late 
1950's and early 1960's (Faden & Beauchamp, 1986).  Although general medicine began 
incorporating informed consent, psychotherapy avoided the widespread use of informed 
consent until the Osherof f v. Chestnut Lodge legal case during the 1980's, which raised 
serious questions about the duty of providers to explain fully, the diagnoses and 
alternative treatments (i.e., risks and benefits) to clients (Beahrs & Gutheil, 2001; 
Klerman, 1990).  Subsequently, client's rights started to become a priority in obtaining 
the most effective and efficacious psychological treatment (Klerman, 1990).  Although 
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Osheroff v. Chestnut Lodge case never reached final court adjudication, it started a dialog 
between mental health and legal professionals (Klerman, 1990).  
 The last century witnessed multiple cases of unethical and uninformed treatment 
of human participants under the guise of research.  The most notable of these infamous 
research cases included the Tuskegee Syphilis, Willowbrook, Tearoom Trade, Jewish 
Chronic Disease hospital, and the Milgram study.  In order to understand the natural 
progression and treatment of syphilis, the United States Public Health Service initiated 
the Tuskegee Syphilis study in 1932, on 399 lower socioeconomic African-American 
males who had syphilis, and 201 controls who did not, from Macon County, Alabama 
(Centers for Disease Control and Prevention [CDC], 2008; Rothman, 1982).  No 
informed consent of any kind was utilized; rather, subjects were coerced into 
participation through a variety of unethical means.  Although penicillin was an accepted 
and effective form of treatment in 1943, its knowledge and usage was deliberately 
withheld from study subjects; neither were participants allowed to obtain any other 
treatment for syphilis (CDC, 2008; Rothman, 1982).  Throughout the forty years of the 
study, 100 subjects died as a direct result of untreated, late stage neurosyphilis (CDC, 
2008; Rothman, 1982).  Although the study was published in several medical journals, it 
was never formally, ethically questioned until 1972, when the press reported on it; the 
result was public outrage.  Similarly, the Willowbrook State Hospital study conducted in 
Staten Island, New York, (from 1963 to 1966), involved a group of children diagnosed 
with mental retardation who were deliberately infected with the hepatitis virus (Rothman, 
1982).  Of primary concern was the coercive manner in which the parents were 
convinced to enroll their children with mental retardation in the study; it was done in 
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exchange for hospital admission and deliberate infection (Rothman, 1982).  In the 
Tearoom Trade study (1960), a researcher who wanted to study the motivations of men 
who had public sex in restrooms, posed as a friend by acting as a “lookout” (Warwick, 
1973).  The researcher then identified the participants by tracking them down by their car 
license plates and posing as a “health-care worker” in order to visit these men at home 
(Warwick, 1973).  In the Jewish Chronic Disease Hospital study in New York, (1963), 
chronically ill, cancer-free patients were injected with live human cancer cells (Galietta 
& Stanley, 2007).  Physicians did not inform their patients (in an effort not to scare them) 
because of the physicians’ beliefs that the cancer cells would be rejected (Galietta & 
Stanley, 2007).  Last, in the classic yet controversial behavioral study on obedience, 
Milgram deceived subjects by misinforming them about the true purpose of the 
experiment, by making them believe they were administering real electric shocks to real 
subjects (Milgram, 1974).  The study raised serious ethical questions about the use of 
human subjects in psychology experiments.  The lack of informed consent among these 
studies and other infamous research cases emphasized the need to protect the rights and 
welfare of human participants in research.  
 Informed consent in treatment originally developed from the notion of the need 
for increased protection applied to research with human participants.  In fact, the 
Nuremberg Code, Declaration of Helsinki, and the Belmont Report issued by the 
NCPHSBR, have declared definitive standards for obtaining informed consent for human 
participant research, prior to beginning medical experiments or for treatments that might 
result in harmful or negative treatment effects. 
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 The 1947 Nuremberg Code (Permissibly Medical Experiments, n.d.) arose out of 
a response to the post-Second World War trials of Nazi doctors who committed heinous 
crimes against humanity on concentration camp prisoners in the name of biomedical trials 
and experiments for research.  The first sentence of the Nuremberg Code asserts 
“voluntary consent of the human subject is absolutely essential”, which highlights the 
importance of the consent requirement in research involving human participants 
(National Institutes of Health [NIH], 2008).  In the case of United States v. Karl Brandt et 
al., the Nuremberg Military Tribunal's decision includes what is now called the 
Nuremberg Code (1947) (Permissible Medical Experiments, n.d).  A ten point statement 
outlining permissible medical research on human subjects is justified only if results are a 
benefit to society at large, and if it is carried out in accordance with basic principles that 
maintain allegiance to moral, ethical and legal standards (NIH, 2008, n.p.).  Some of 
those principles include ensuring the rights of human participants in research.  The most 
notable of these directives for human experimentation, according to the Office of 
Scientific Research, National Institutes of Mental Health (NIMH, 2008) include:  
(a) informed, voluntary consent, (b) research must be purposeful and necessary 
for the benefit of society, (c) research must be based on animal studies or other 
rational justification, (d) avoidance and protection from injury, and unnecessary 
physical and mental suffering, (e) risks to the subject shall not be greater than the 
humanitarian importance of the problem, (f) investigators must be scientifically 
qualified, and (g) subject may terminate the experiment at any time (n.p.). 
 The Nuremberg Code's (1947) requirement for individual consent to participate in 
research, include four factors outlined by Levine (1995); these are: the ability to exercise 
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free choice, possess the legal capacity, have sufficient comprehension to make a decision, 
and have sufficient knowledge to decide (Emanuel et al., 2003).  If any of these four 
conditions are compromised, ethical acceptability of consent itself is imperiled.  Levine 
(1995) argues that the Nuremberg Code's (1947) usage of the term “voluntary consent” 
rather than “informed consent,” indicate primary focus on the notion of “freedom of 
choice” -  rather than on “quality or quantity of information transmitted” (as cited in 
Emanuel et al., 2003, p. 199).  The “free power of choice” objective includes “any 
element of force, fraud, deceit, duress, overreaching, or other ulterior forms of constrain 
or coercion” must not be present in obtaining consent (Emanuel et al., 2003, p. 199).  
 The knowledge or information component of the consent process is what makes it 
informed.  There is much debate over the kind of information potential that research 
participants need in order for them to make an informed decision.  Katz reveals that 
potential participants “still may fail to understand when a proposed intervention poses 
uncertain and perhaps significant risks or offers no prospect of therapeutic benefit to 
them as individual patients” (as cited in Siminoff, 2003, p. 1).  Research literature reveals 
the fact that most research participants have significant gaps in the ability to recall and 
understand information presented during informed consent; information tends to be 
relayed in a manner that is difficult to understand, and information from consent forms 
are frequently hard to read and absorb (Kent, 1996; Tuckett & Williams, 1984; Meade & 
Howser, 1992; Wu & Perlman, 1988).  Siminoff (2003) indicates that patients, “are 
limited in their ability to assimilate very large amounts of new information quickly”, in 
order to make an informed decision (p. 2).  In a large NIMH (1997) study conducted in 
various locations (large hospitals and outpatient offices) on informed consent, researchers 
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examined the needs of vulnerable populations (individuals with cognitive impairment and 
the critically ill), including the quality of consent (forms), the process of obtaining 
consent, decisions made and recalled, anxiety, proxy decision-makers and other 
psychosocial outcomes (Siminoff, 2003).  Several findings revealed that the importance 
of the clinical setting and the context of the illness are important factors for informed 
consent (Siminoff, 2003).  Interestingly, individuals whose surrogates made decisions for 
them, made choices significantly different from the participants themselves; this resulted 
in a greater “thresholds for risk” when decisions were made by another person (Siminoff, 
2003, p. 2).  This study underscores the importance of the need to have informed consent 
research, based on theories of communication and decision-making (Siminoff, 2003).   
 The Nuremberg Code's (1947) requirement to consent, as outlined by Levine 
(1995) include both a “legal capacity to consent” (often referred to as “competence”) and 
“sufficient understanding” in order to reach an “enlightened decision” (as cited in 
Emanuel et al., 2003, p. 199).  Levine (1995) argues that within the definitions of 
competence are elements of comprehension related to an individual’s ability to “evaluate 
relevant information, understand the consequences of action, and to reach a decision for 
rational reasons” (as cited in Emanuel et al., 2003, p. 199).  An assessment for 
incompetence, according to Levine (1995) includes four basic themes:  
(1) Reasonable outcome of choice. This is highly paternalistic standard because 
the individual's right to self-determination is respected only if he or she makes the 
“right” choice – that is, one that accords with what the competency reviewer 
either considers reasonable or presumes a reasonable person might make; (2) 
Factual comprehension.  The individual is required to understand, or at least be 
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able to understand, the information divulged during the consent negotiation; (3) 
Choice based on rational reasons. Individuals must demonstrate a capacity for 
rational manipulation of information.  They may, for example, be required to 
show that they not only understand the risks and benefits but also have weighted 
them in relation to their personal situations; (4) Appreciation for the nature of the 
situation. Individuals must demonstrate not only comprehension of the informed 
consent information but also the ability to use the information in a rational 
manner.  Furthermore, they must appreciate the fact that they are being invited to 
become research subjects and what that implies (as cited in Emanuel et al., 2003, 
p. 200). 
The U.S. Presidential Commission for the Study of Ethical Problems in Medicine 
and Biomedical Research (2008) (hereinafter, U.S. President's Commission) outlines the 
requirements for individual capacity to make a decision, “(1) possession of a set of values 
and goals; (2) the ability to communicate and understand information; and (3) the ability 
to reason and deliberate about one's choices” (n.p.).  Although the U.S. President 
Commission (2008) endorsed an individual's capacity for assessment, it recommends a 
balance between well-being and self-determination related to potential consequences of a 
patient's decision.  Specifically, when the consequences for well-being are substantial, 
there is a greater need to be certain that the patient possesses the necessary level of 
capacity.  
 Research on informed consent is inconsistently related to what constitutes 
appropriate assessment for competence.  According to Plaut (1989), the issue of 
competence related to an individual's ability to give truly informed consent, creates many 
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ethical dilemmas.  Although there are no obvious difficulties at either end of the 
spectrum, because “the fully conscious, rational patient under no duress can of course 
give informed consent; the unconscious or totally confused and disoriented patient 
cannot,” Plaut (1989) argues that there exists “a large gray area in between” (p. 436). 
Interestingly, there appear to be no specific legal cases or precedents to guide research. 
Although the traditional standards for guardianship and ability to stand trial exist, they do 
not seem applicable or appropriate to informed consent (Plaut, 1989).  Although a 
determination of incompetence appears relevant for informed consent, it tends to impact 
very few areas of the ability to make decisions.  For example, Levine (1995) argues that 
an individual who is legally competent may not be functionally incompetent, just as 
someone who is legally incompetent can be thought functionally competent (Emanuel et 
al., 2003).  Even though lacking legal capacity or comprehension is prohibited for 
participant research by the Nuremberg Code (1947), this is not the case in all Codes. 
Most Codes and guidelines discuss obtaining permission for consent from the legal 
guardians of those individuals lacking the adequate capacity to give consent.  
 Adequate disclosure to the patient, according to the Nuremberg Code (1947), 
require as Levine (1995) asserts, the potential participant be told “the nature, duration, 
purpose of the experiment; the methods and means by which is conducted, all 
conveniences and hazards reasonably to be expected; and the effects upon his health or 
person which may possibly come” (as cited in Emanuel et al., 2003, p. 200).  The U.S. 
Code of Federal Regulations (hereinafter, CFR) have expanded on these codes and 
regulations to include: 
INFORMED CONSENT IN PSYCHOTHERAPY 29 
(1) a statement of the purpose of research and a description of its procedures; (2) a 
description of foreseeable risks and discomforts; (3) a description of benefits; (4) 
disclosure of appropriate alternatives, if any; (5) a statement of the extent of 
confidentiality; (6) an explanation of the availability of medical treatment for 
injury and compensation for disability; (7) an explanation of whom to contact for 
answers to questions; and (8) a statement that participation is voluntary and that 
neither refusal to participate nor withdraw at any time will result in a loss of 
benefits to which the subjects is otherwise entitled (CFR, 2008, n.p.). 
There appears to be no universal agreement on standards for disclosure of information 
and/or what it takes for a person to have sufficient knowledge to give informed consent 
(Emanuel et al., 2003).  Levine (1995) argues that those who “agree on the need for 
disclosure of information in a particular category – the risks for example, often disagree 
on the nature of the information that must be made known” (as cited in Emanuel et al., 
2003, p. 201).  Levine (1995) suggests, for example, that it is unclear, in the Nuremberg 
Code (1947) where it describes “explication of hazards 'reasonably to be expected,'” 
whether this means there could be a “very slight chance of substantial harm, or a 
substantial chance of a very slight harm” (as cited in Emanuel et al., 2003, p. 201). 
Similarly, within the legal context, neither the “quality nor the probability of risks to be 
divulged has been clearly determined” (Emanuel et al., 2003, p. 201).  
 The Nuremberg Code (1947) failed to produce a broader “legal doctrine 
protecting individuals against harm induced by scientific practices at large, including not 
only human beings as subjects of medical experiments but also as consumers and 
beneficiaries of science's outcomes” (Thieren & Mauron, 2007, p. 1).  The Nuremberg 
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Code (1947) is often thought of as the predecessor of later codes which intend to assure 
an ethical manner for human participant research.  Because the Nuremberg Code (1947) 
does not address research in patients with illnesses, the Declaration of Helsinki (1964) 
has been thought to be more preferable ethical guide for patient/client experimentation in 
research.  
 The Declaration of Helsinki's (1964) original document, much like the Nuremberg 
Code (1947) was written in response to the unethical medical experiments of the Nazi 
physicians during the Second World War.  While the publication has been revised several 
times by the World Medical Association (WMA), the latest version asserts that "the well-
being of the human subject should take precedence over the interest of science and 
society" (WMA, 2000).  Physicians are expected to both act in their patients’ best interest 
and to view an individual's heath and overall well-being as priority.  The main principles 
of this document are incorporated in a great number of national research regulations and 
guidelines.  The most recently revised declaration asserts the following regarding 
informed consent:  
In the treatment of a patient, where proven prophylactic, diagnostic and 
therapeutic methods do not exist or have been ineffective, the physician, with 
informed consent from the patient, must be free to use unproven or new 
prophylactic, diagnostic and therapeutic measures, if in the physician's judgment 
it offers hope of saving life, re-establishing health or alleviating suffering.  Where 
possible, these measures should be made the object of research, designed to 
evaluate their safety and efficacy.  In all cases, new information should be 
recorded and, where appropriate, published (WMA, 2000, n.p.). 
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 In 1947 the National Research Act was passed by the United States Congress. 
Although both international codes, the Nuremberg Code (1947) and the Declaration of 
Helsinki (1964) were generally used as guides for researchers conducting 
experimentation with participants, the United States government continued to sponsor 
unethical human experimentation (Zimmerman, 1997).  The NCPHSBR, created by the 
National Research Act (1947), included professionals from ethics, science, and the law, 
who made recommendations to the Department of Health and Human Services 
(hereinafter, DHHS).  One of the Commission's statements was The Belmont Report: 
Ethical Principles and Guidelines for the Protection of Human Subjects of Research, or 
commonly referred to as the Belmont Report (1979).  Although the Belmont Report 
(1979) never officially endorsed many of the recommendations, it became the basis for 
subsequent DHHS laws.  The United States Congress enacted both, titled Protection of 
Human Subjects (FDA regulation 21 CFR Part 50 and PHS regulation 45 CFR Part 46; 
FDA regulation 21 CFR Part 56 [Institutional Review Boards]); however, there are still, 
surprisingly, no national policies to outline protection of human research participants 
(Zimmerman, 1997).  Zimmerman (1997) notes that the DDHS mandates appear too 
“restrictive and inflexible to be used as a dynamic foundation for evolving biomedical 
ethics” (n.p.).  Despite the lack of endorsement by United States Congress and DHHS, 
the Belmont Report (1979) remains widely recognized as an international guideline for 
protecting individuals in clinical trials research. 
 As a result of the Belmont Report (1979) principle, “respect for persons”, 
potential participants were no longer considered “passive objects for scientific 
investigations or trials but were to be seen as having an inviolable autonomy” (Walker et 
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al., 2005, p. 244).  Potential research participants were given the opportunity to decide to 
participate through adequate information, assessment of comprehension, and most 
important, as true and actual volunteers.  It was necessary that adequate information 
relative to informed potential participants' understanding be given, that “research is 
neither necessary for their well being nor are the effects of the research fully known or 
understood,” and that “if a direct benefit to subjects is expected, they should clearly 
understand the range of risks” (Zimmerman, 1997, n.p.).  
 The ethical principles outlined in the Belmont Report (1979) were designed to aid 
in establishing guidelines for the development of biomedical and behavioral research 
with human participants.  Respect for persons, beneficence, and justice are the three 
fundamental ethical principles that underlie human participation and informed consent 
(Walker et al., 2005; NCPHSBBR, 1979).  Embedded within these principles are 
corollary applications to psychotherapy treatment practices and informed consent.  For 
example, respect for persons implies that individuals be “treated as autonomous agents” 
(Walker et al., 2005, p. 244) and assumes two ethical presumptions.  The first assumption 
is that people must be treated as autonomous individuals, capable of making their own 
decisions by possessing the capacity for self-determination.  The other presumption 
assumes that not every individual is capable of self-determination; rather, “some 
individuals may lose the capacity for self- determination because of physical illness, 
mental disabilities, or situations that restrict personal freedom” (Zimmerman, 1997, n.p.). 
Beneficence relates to the idea or practice of “doing good” in order to improve an 
individual’s overall well-being, and justice dictates that during the treatment process, 
every individual must be treated in a manner that is fair and equal (Zimmerman, 1997, 
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n.p.).  Respect for persons, beneficence, and justice outlined by the APA's Code of Ethics 
are embedded in the foundation of informed consent.  
Informed Consent Functions 
 Katz and Capron present an overview of the functions of informed consent; these 
are, “to promote individual autonomy; encourage rational decision making; avoid fraud 
and duress; involve the public; encourage self-scrutiny by the physician-investigator; and 
reduce the civil and or criminal liability of the investigator and his or her institution” (as 
cited in Emanuel et al., 2003, p. 198).  Information transmission is at the core of 
obtaining informed consent (Siminoff, 2003).  Informed consent is a moral, ethical, and 
legal obligation in medical, psychiatric, and psychological treatment and research (Berg 
et al., 2001; Faden & Beauchamp, 1986).  Human participant research is regulated by 
both federal law (CFR, Title 45, Part 46, 1994) and university or agency Institutional 
Review Boards (IRB).  These IRB's monitor, design and ensure that informed consent is 
consistent with the federal regulations, guidelines and ethics.  
 There is a clear distinction articulated by researchers between “genuine informed 
consent” related to the communication process, and the “bureaucratic trappings” of a 
consent form and signature (Emanuel et al., 2003, p. 189).  According to Levine (1995), 
“genuine informed consent is supposed to serve the rights and welfare of potential 
participants in research”, whereas the use of consent forms “largely serves the legal and 
financial interests of researchers and their institutions” (as cited in Emanuel et al., 2003, 
p. 189).  Although the “negotiations for informed consent are designed to safeguard the 
rights and welfare of the subject,” Levine (1995) asserts, “documentation that the 
negotiations have been conducted properly safeguards the investigator and institution” (as 
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cited in Emanuel et al., 2003, p. 198).  Although the actual consent signature obtained on 
a form for research is advantageous for the investigator, Levine (1995) argues it could 
result in privacy and confidentiality violations, resulting in the “net effect” construed as 
“harmful to the interests of the subject” (Emanuel et al., 2003, p. 198).  Levine (1995) 
asserts that, “federal regulations permit wavers of the requirements for consent forms 
when the principal threat to the subject would be a breach of confidentiality and the only 
record linking the subject and the research would be the consent document” (as cited in 
Emanuel et al., 2003, p. 198).  This exception, however, does not pertain to the informed 
consent process.  Federal regulations appear to focus primarily on the consent form itself, 
rather than the process as a whole (Emanuel et al., 2003).  Information about what is 
included and what is excluded on consent forms (both in research and practice) remains 
an area of debate.  Levine (1995) views informed consent as “a discussion or 
negotiation”; Katz, on the other hand, “envisions consent as a searching conversation” (as 
cited in Emanuel et al., 2003, p. 198).  Researchers generally agree, however, that 
informed consent should be viewed as a continual process rather than as a one-time event 
(such as obtaining a signature on a consent form). 
 Although research consent is primarily geared toward “the fulfillment of a 
scientific aim,” Roberts, Geppert, and Baily (2002) indicate, “clinical consent is oriented 
toward the patient benefit” (p. 292).  There is a debate whether or not informed consent to 
research should be conducted by a different standard or set of criteria, than informed 
consent in psychology practice (Emanuel et al., 2003).  Some authors argue it is 
unnecessary to negotiate the informed consent process formally when the “interests of 
research and practice are conjoined”; however, others argue that there should be “higher 
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requirements for informed consent... imposed in therapy...particularly when an honest 
experimentation is joined with therapy” (Emanuel et al., 2003, p. 198).  These researchers 
point out that “patients are entitled to the same degree of thoroughness of negotiations for 
informed consent as are subjects of research” (Emanuel et al., 2003, p. 198).  Although 
the bioethics literature and CFR appear to impose more demanding research 
requirements, Levine (1995) argues “both patients and research participants should be 
afforded the same rigorous protection in this regard” (as cited in Emanuel et al., 2003, 
189). 
 There is, however, with the exception of clinical trials research, no immediate 
oversight or monitoring of the informed consent process for psychotherapy practice 
(Smith, 2001).  As a consequence, there are no clear stated standards or clinical 
guidelines on informed consent implementation into the everyday clinical practice. 
Although it is generally understood that potential clients should be informed, prior to 
engaging in psychotherapy, about the “relative efficacy, efficiency, and safety of the 
recommended treatment and its primary alternatives as well as the likely consequences of 
no treatment” (Beahrs & Gutheil, 2001, p. 8), the specifics related to informed consent 
content and practice appear to be decided on an as-needed basis, depending on the needs 
of the client. What constitutes sufficient and appropriate fully informed consent in 
clinical practice remains unclear. 
The Ethics Codes 
 In searching for standardized criteria or for guidance about implementation of 
informed consent, a review of the major mental health profession's ethics codes and 
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guidelines suggests that there are few common elements among the ethics codes related 
to understanding and implementation of informed consent. 
 The medical model.  In the precedent setting case, Canterbury v. Spence (1972), 
the United States Court of Appeals asserted the following regarding the standards of 
informed consent:  
(a) that consent is the informed exercise of a choice; (b) that every adult human 
being of sound mind has a right to determine what shall be done with his/her 
body; (c) that the doctor must disclose all "material risks" based on the "prudent 
patient" test; and (d) that the doctor can withhold information from the patient 
concerning the risk only if it can be shown that the disclosure would result in 
serious adverse psychological consequences to the patient (n.p.). 
Judicial decisions have primarily determined standards of disclosure from informed-
consent proceedings (Jensen et al., 1991).  Knapp and VandeCreek (2006) note 
“malpractice courts have used the 'reasonable person' standard to determine what 
information should be given to patients” prior to agreeing to undergo a medical procedure 
(p. 100).  As a guide for physicians, the American Medical Association's (AMA) Code of 
Medical Ethics (2006 - 2007) (hereinafter, AMA Ethics Code) has undergone many 
revisions since its inception in 1847, and continues to set the standard for practicing 
medicine for physicians and health care providers.  The AMA Ethics Code asserts that 
part of overall good medical practice includes the physician's obligation to his or her 
patient to make sure all medical facts are accurately presented in order to be able to make 
a treatment decision.  With the recent changes in general social policy, the previously 
held paternalistic view, whereby physicians tended not to present patients with alternative 
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treatment options, in order to ensure patients remaining in treatment, are no longer valid. 
There are few, if any, specific guidelines, however, advising physicians about what to 
include during informed consent (AMA Ethics Code).   
 The psychiatric model.  Since the first edition of American Psychiatric 
Association's (APA) Principles of Medical Ethics (1973), the APA's Board of Trustees 
and Assembly have determined numerous editions to these principles; the most recent 
include changes in 2001 to the principles.  The basic medical-ethical principles of 
physician-patient contact are the same; however, the psychiatric profession added some 
specific ethical issues. The APA Principles of Medical Ethics (2008) assert “a physician 
shall respect the rights of patients, colleagues, and other health professionals, and shall 
safeguard patient confidences and privacy within the constraints of the law” (APA, 
2008).  In regard to providing informed consent, the APA (2008) notes: 
Psychiatrists have a long and valued tradition of being essential participants in 
organizations that deliver health care. Such organizations can enhance medical 
effectiveness and protect the standards and values of the psychiatric profession by 
fostering competent, compassionate medical care in a setting in which informed 
consent and confidentiality are rigorously preserved, conditions essential for the 
successful treatment of mental illness.  
 Although informed consent in psychiatric practice includes the aforementioned 
contractual arrangement between the patient and the physician which is to be “rigorously 
preserved”, there is no specific reference regarding informed consent to undergo 
psychotherapy or pharmacological treatment as part of establishing the treatment contract 
(APA, 2008).  The APA (2008) briefly mentions ethics regarding presentation of a case 
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to a scientific meeting, during which the physician must ensure “dignity and privacy - 
with truly informed consent,” which includes maintaining patient confidentiality during 
presentation (n.p.). 
 The psychological model.  The psychological profession, as a whole, views 
informed consent as one of the primary ways of protecting both the self-governing and 
the privacy rights of clients.  Informed consent is also seen as helping to maintain a 
“culture of safety” (Knapp & VandeCreek, 2006, p. 100).  The current Ethics Code 
(2002) includes broader informed consent requirements, than previous editions, both in 
structure and in content (i.e., 1992 edition limited informed consent to research and 
therapy).  The 1992 Ethics Code marked the first distinction in separating aspirational 
from mandatory ethics.  The current Ethics Code (2002) reflects the recent societal 
changes of moving from a rather paternalistic manner to a more autonomy-based view in 
which both professional and scientific ethics are concerned (Fisher, 2003).  Fisher (2003) 
notes “for the first time clear distinctions were made between aspirational principles that 
articulated foundational values of the discipline and specific decision rules articulated in 
180 distinct ethical standards that would be subject to enforcement by the APA, other 
organizations, and licensing boards that adopted them (Canter, Bennet, Jones, & Nagy, 
1994)” (p. 6).  The Ethics Code (2002) provides specific guidelines for informed consent 
in order to undergo assessments, treatments and research, including provisions for assent 
among persons who have limited ability to provide assent.  The Ethics Code (2002) 
dictates enforceable rules or ethical standards for conduct among psychologists.  The 
following are outlined by the Ethics Code (2002) regarding minimum standards of 
informed consent to therapy: 
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(a) When obtaining informed consent to therapy as required in Standard 3.10, 
Informed Consent, psychologists inform clients/patients as early as is feasible in 
the therapeutic relationship about the nature and anticipated course of therapy, 
fees, involvement of third parties, and limits of confidentiality and provide 
sufficient opportunity for the client/patient to ask questions and receive answers. 
(b) When obtaining informed consent for treatment for which generally 
recognized techniques and procedures have not been established, psychologists 
inform their clients/patients of the developing nature of the treatment, the 
potential risks involved, alternative treatments that may be available, and the 
voluntary nature of their participation (Ethical standard 10.01, p. 1072). 
In practice, psychologists are obligated to ensure that potential clients have been given 
sufficient information in order for them to make an informed decision prior to engaging 
in psychotherapy.  An informed consent discussion not only protects the rights of client 
autonomy and self-direction, but it is thought also to enhance subsequent participation 
and responsibility of engaging in psychotherapy (Coyne & Widiger, 1978).  The Ethics 
Code (2002) indicates that in order to increase client autonomy, psychologists “obtain the 
informed consent of the individual or individuals using language that is reasonably 
understandable to that person or persons” (Standard 3.10, Informed Consent, p. 1065).  In 
order to ensure adequate comprehension, careful consideration regarding an individual’s 
capacity to understand, includes language at a level the individual can understand and 
absorb.  If the consenter does not comprehend or understand information presented to 
him or her, the informed consent becomes invalid (Zimmerman, 1997).  An 
implementation of informed consent procedures has been mandated as an ethical 
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responsibility for psychologists; however, guidelines concerning the content are vague 
and open to individual interpretation.  For example, in a discussion of therapeutic risks 
and benefits (see Section 10.01b) regarding informed consent, according to the Ethics 
Code (2002), appears merely to be implied.  An implied discussion allows practicing 
psychologists a substantial amount of leeway regarding those topics to be included as part 
of a conversation about risks, resulting in significant variation within informed consent 
practices. 
Informed Consent and Implementation 
 Research suggests various models to help define the direction of informed consent 
and to understand its implementation into the clinical setting (Lidz, Appelbaum, & 
Meisel, 1988; Walker et al., 2005).  The “event model” is thought of as a onetime event 
during which informed consent is given at one specific point in time, usually at the 
beginning of treatment; this has its roots in legal doctrine.  Because of an emphasis on the 
idea that information is more important than the individual's understanding, a consent 
form is often used with this model (Braaten & Handelsman, 1997).  Lidz et al. (1988) 
note some advantages for using this model, including a clear outline of potential client 
goals; however, this model is problematic for psychotherapy.  The information presented 
is often “too complex for the patient to understand without reflection and dialog, and 
frequently constitutes a formalistic effort to comply with the law, at the expense of the 
real collaboration” (Lidz et al., 1988, p. 1388).  Braaten and  Handelsman (1997) reveal 
“Patients with certain disorders, such as major affective disorders, may be competent to 
consent to treatment but may need to be provided with different information once their 
symptoms abate” (p. 313).  Other problems with this model include the assumption that 
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psychotherapy involves only a one-time decision, separate from the process of informed 
consent.  Not only is this model paternalistic, Braaten and Handelsman (1997) noted “It 
provides a poor model for many clients who are seeking treatment in order to regain a 
sense of power and autonomy in their lives” (p. 313).  
 The “process model” on the other hand, addresses informed consent, “as an 
integral and continuous part of the relationship between patients and physicians 
embedded in the treatment process,” with clients providing active participation in their 
treatment decision-making, over time (Lidz et al., 1988, p. 1385).  Consent is seen as a 
dynamic process which happens within the “context” of the provider-client relationship 
(Childress & Fletcher, 1994).  The process portion of consent is a “systematic disclosure 
of information to the client over time”- over the course of psychotherapy (Reamer, 1987, 
p. 428).  There is also an element within consent which remains part of the personal 
process and tends to be specific to each individuals treatment (Arboleda-Florez, 1987). 
The informed consent process provides a more substantial effect on the therapist-client 
relationship.  Clients are seen to have an active role in the process; this enhances the 
interaction between therapist and client, allowing clients the opportunity to make 
treatment decisions.  This may not only enhance client autonomy and further treatment 
goals, it can also “help therapists monitor the course of treatment and, perhaps, provide 
therapists with information about their own effectiveness” (Braaten & Handelsman, 1997, 
p. 313).  Lidz et al. (1988) concluded that the emphasis on the need for participation is 
beneficial for the client and “contributes to therapeutic outcomes” (p. 1388).  
 Most current research view informed consent as a process to be conducted over 
time (e.g., Dyer & Bloch, 1987; Hass, 1991).  Hass (1991) recommends beginning the 
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informed consent process with more general and universal aspects of the proposed 
treatment and then moving toward more specific descriptions of procedures and 
implications on an as-needed basis.  Manning and Gaul (1997) note that when an 
individual is experiencing an “emotionally traumatic experience it is difficult to capture 
and retain what has been said, let alone the meaning of what has been said” (p. 108). 
These authors suggest an “opportunity to reflect, ask more questions that stimulate the 
need for specific information” regarding their proposed treatment leads clients to a more 
highly informed decision over time (Manning & Gaul, 1997, p. 108).  
 The phrase “as early as feasible” in ethical standard 10.01a  (APA, 2002, p. 1072) 
suggests that there may be times when obtaining informed consent during the first 
meeting may not be appropriate.  Studies suggest that psychotherapy should not be “an 
all-or nothing” experience; rather, it should be an on-going process conducted over time 
(Pomerantz, 2005).  For example, O'Neill (1998) has suggested that potential problems 
change in psychotherapy over time, resulting in a need to change a treatment approach; 
therefore, a one-time consent presented before these changes occur does not adequately 
reflect treatment changes or the consent itself.  Stone (1990) regarded informed consent 
as a process and not a single set “formula regardless of the actual situation” (p. 425). 
Knapp and VandeCreek (2006) suggest “psychologists can sometimes titrate the 
information given to patients”, whereby “they present the patient with a limited amount 
of information, determine how well the patient is able to understand and integrate that 
information, and then provide additional information as needed” (p. 103).  Hass (1991) 
recommends informed consent be treated as both a prerequisite to engage in 
psychotherapy and as part of the ongoing treatment process.  Pomerantz (2005) asserts 
INFORMED CONSENT IN PSYCHOTHERAPY 43 
that informed consent to psychotherapy “is better conceptualized as a process that 
evolves with psychotherapy rather than as single even that precedes it” (p. 352). 
 Faden and Beauchamp (1986), as outlined by Walker et al. (2005), describe two 
requirements for informed consent.  First they reveal that informed consent is an actual 
“authorization of treatment by an informed and intentional patient”, whereas the second 
is “more of an institutional one that observes the correct legal means for obtaining 
consent” from individuals seeking psychotherapy (Walker et al., 2005, p. 244).  With the 
second one there is a greater emphasis on meeting the legal requirements, which include 
the consent signature being a “defining moment of the consent process” (Walker et al., 
2005, p. 244).  Rather than merely signing a consent form, these researchers assert that 
“clients should more than simply comply with treatment: they should actively authorize it 
as autonomous agents or take the opportunity to exercise control over their decisions” 
(Walker et al., 2005, p. 244).  Dyer and Bloch (1987) viewed the clinical informed 
consent process as occurring “within the framework of a fiduciary relationship whereby 
therapists identify specific needs of patients and respond individually without the use of 
written contract or forms” in which this “fiduciary relationship is one based on mutual 
trust, confidence, and openness” (as cited in Braaten & Handelsman, 1997, p. 313).  
 The manner in which informed consent is obtained in research has significant 
application to the informed consent process in practice.  Obtaining informed consent to 
undergo research and treatment in clinical trials, “has become a routine expectation as a 
way to promote self-determination and autonomy” (Walker et al., 2005, p. 243). 
Although informed consent procedures among research settings has received a significant 
amount of attention and has resulted in formal consent procedures (regulated by IRB in 
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academic settings), there is less evidence for protection of clients either by completed 
procedures or by guidelines among clinical practice settings.  In fact, Hare-Mustin, 
Marecek, Kaplan, and Liss-Levinson (1979), reveal that in their opinion, the primary 
motivating factors for the use of informed consent procedures for psychotherapy were 
therapist's protection from malpractice lawsuits and as a way to safeguard psychology 
from outside regulation.  Regardless of the rationale, Handelsman, Kemper, Kesson-
Craig, McLain, and Johnsrud (1986) emphasize the importance of providing written 
information to clients at the onset of psychotherapy.  Knapp and VandeCreek (2006) 
suggest the “content of informed consent procedures is intended to anticipate questions 
that most reasonable patients would have and to prevent future misunderstandings and 
disappointments” (p. 100).  The ultimate goal for these consent procedures (provided 
correct implementation) consists of “open exchanges between psychologists and their 
patients” (Knapp & VandeCreek, 2006, p. 100).  
 The ethical responsibility of psychologists to practice informed consent is clear; 
however, there is little consensus regarding procedures related to the use of oral or 
written consent forms for psychotherapy (APA, 2002; Everstine et al., 1980; Hare-Mustin 
et al., 1979; Morrison, 1979; Schwitzgebel, 1976).  Muehleman, Pickens, and Robinson 
(1985) note that no more than one-third of practicing psychologists use verbal consent 
from their clients for psychotherapy.  Authors have advocated that written forms include 
a description of goals, procedures, risks, and benefits for psychotherapy (Hare-Mustin et 
al., 1979; Handelsman & Gavin, 1988; Morrison, 1979).  Handelsman and Gavin (1988) 
advocate for a combination of an informed consent format which includes an initial 
written section in which clients indicate information that interests them, with concerns 
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subsequently addressed orally by the therapist before initiation of therapy.  These authors 
present a written format that includes open-ended questions that a client has the right to 
ask upon entering psychological treatment.  An open-ended format “has several 
advantages over narrative forms: it preserves clients' right to refuse information; it is less 
overwhelming; it fosters conversation between therapist and client, and it is readable” 
(Handelsman & Gavin, 1988, p. 223).   
 Research is varied regarding the use of consent forms.  For example, in a survey 
study of psychologists in private practice, 28 percent of those who responded (53 percent) 
endorsed using an informed consent form; the primary reason for not using a form is a 
preference for oral informed consent (Handelsman et al., 1986).  Results from this study 
reveal forms from psychotherapy practice generally dealt with fees and not “information 
that satisfies the requirements of informed consent, such as risks of treatment and 
alternative treatments” (Handelsman et al., 1986, p. 514).  Among the 19 consent forms 
collected in their study, only one mentioned possible risks, and none of the consent forms 
outlined “benefits or risks to be expected of alternative treatments, or prognosis without 
treatment” (Handelsman et al., 1986, p. 516).  Although Handelsman et al. (1986) note 
that they do not necessarily endorse using a consent form, they articulate “increased 
sensitivity to the issues involved”, including the fact that the potential risks are of 
primary importance (p. 516).  Hare-Mustin et al. (1979) argue strongly for information 
related to risks involved and for alternative treatment to be included, at the onset of 
psychotherapy, in any informed consent procedure.  
 Handelsman et al. (1986) note that because consent forms do not necessarily 
guarantee informed consent, more sensitivity to the issues involved is warranted. 
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Croarkin, Berg, and Spira (2003) note “state psychological associations have examined 
these procedures and recommend that patients be offered documents at the outset of 
treatment” (p. 399).  Researchers suggest presenting clients with “a patient's rights form, 
treatment-contract form, and an informed-consent form” at the beginning of treatment 
(Croarkin et al., 2003, p. 399).  Giving a client these forms, according to Horowitz 
(1984), not only emphasizes the voluntary nature of engaging in psychotherapy, but also 
that there are inherent risks which clients need to know about.  Addressing risks, 
including potentially negative treatment effects during the informed consent process 
appears consistent with these fundamental goals of informed consent, as part of creating a 
dialog or exchange between clients and psychologists.  
Informed Consent and Risk 
 One of the main responsibilities of psychologists is to ensure the informed rights 
of their clients relative to potential risk (Hare-Mustin et al., 1979).  Handelsman and 
Gavin (1988) assert “therapists still must judge whether a given risk or alternative is so 
important that a particular client absolutely needs to know, they must answer the 
questions objectively and clearly, and they must ensure that clients understand and are 
satisfied with the material presented” (p. 224).  One of these responsibilities includes 
providing individuals with the knowledge of potentially negative effects as a result of 
psychotherapy.  Information regarding what constitutes risks or negative indirect effects 
is essential in order for a client to be able to weigh the benefits and risks upon entering 
treatment (Hare-Mustin et al., 1979).  The psychology profession has been “more 
proactive in regard to establishing informed consent for psychotherapy as a standard of 
care” (Croarkin et al., 2003, p. 399); however, there is considerable variability among 
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practices regarding addressing risk during the informed consent process (Handelsman et 
al., 1986; Noll & Haugan, 1985).  
 Although there is published literature suggesting informed consent content, less is 
known about clinicians' actual informed-consent procedures.  Most of the research in the 
area of informed consent consists of surveys reporting alleged informed consent content 
among consent forms.  Although there is clear responsibility on behalf of psychologists to 
inform their clients fully about potential risks related to psychotherapy, an adequate, 
outlined procedure appears to be lacking.  Subsequently there appears to be little 
agreement about what those potential risks should include.  In their study examining 
opinions and practices of psychotherapists, Croarkin et al. (2003) reveal that practices for 
informed consent vary with the characteristics of the therapists.  Results from content 
analyses of written consent forms reflect a wide variation of information used by 
psychologists (Handelsman et al., 1979).  In their study, Talbert and Pipes (1988) 
conducted a content analysis of 40 consent forms used by psychological services.  Results 
indicated inconsistent content, and only 1 of the 40 forms mentioned possible risks of 
engaging in psychotherapy.  However, Somberg et al., (1993) surveyed psychotherapists’ 
attitudes and beliefs regarding informed consent, including potential risks of 
psychotherapy.  Data revealed that 48 percent of clients were informed about risks 
(Somberg et al., 1993).  Noll and Haugan (1985) reported similar results, indicating that 
approximately 40 percent of psychologists inform their clients about potential risks (e.g., 
confidentiality issues).  However, a discussion of potential risks by the clinician, 
according to Noll and Haugan (1985), was more highly preferred when relevant 
situations presented during the course of psychotherapy.  One reason for delayed 
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presentation of possible risks of therapy, Noll and Haugan (1985) hypothesize, is that 
clinicians may feel information of risks could potentially overwhelm possible clients and 
deter them from engaging in psychotherapy.  Results from a study conducted on a 
German speaking population, Dsubanko-Obermayr and Baumann (1998) found that a 
higher percentage (68 percent) of clients were informed of risks during informed consent 
when compared with the  results of Stomberg et al. (1993) and Noll and Haugan (1985). 
A possible reason for the apparent difference, according to Dsubanko-Obermayr and 
Baumann (1989), may be “explained by a different comprehension of the term 'risk' (e.g., 
family changes, straining periods, failure of therapy, stigma, and so on)” (p. 243). 
Although addressing risks in therapy may be considered generally relevant, more 
research is needed regarding psychologists' attitudes and practices related to addressing 
potential negative effects of psychotherapy during the informed consent process.  
 As part of the information process, Hare-Mustin et al. (1979) assert the need to 
include, as part of a conversation of risk, potential negative effects as a result of engaging 
in psychotherapy (Hare-Mustin et al., 1979).  Braaten and Hadelsman (1997) found both 
current and former therapy clients wanted information about confidentiality, risks of 
alternative treatments and inappropriate therapeutic techniques as opposed to information 
such as therapist personal characteristics and professional training, which were rated as 
least important.  Similarly, in their study looking at what client's considered preferable 
information during informed consent, Jensen et al. (1991) surveyed 173 parents of 
elementary school-aged children regarding potential psychotherapy for their children. 
The parents placed a stronger emphasis on disclosure of information related to iatrogenic 
risks then did the therapists (Jensen et al., 1991).  Prior to the onset of psychotherapy, 95 
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percent of the parents wanted information about therapeutic risks (Jensen et al., 1991).  In 
an earlier study conducted by the same authors (Gustafson, McNamara, Jensen, 1988), 
child clinical psychologists were surveyed and rated iatrogenic risk as only moderately 
important information to include during informed consent.  Interestingly, however, there 
appeared to be a high correlation among these child psychologists between therapeutic 
risk-benefit importance ratings and their reported frequency of discussion of such issues 
with their clients (Gustafson et al., 1988).  In a national survey study on psychotherapy 
outcome, Boisvert (1999) found respondents to be “either incorrect about research 
findings on iatrogenic effects (i.e., they tended to underestimate the frequency of negative 
outcomes) or simply indicated that they were unaware of research in this area” (as cited 
in Boisvert & Faust, 2002, p. 247).  Dsubanko-Obermayr and Baumann (1998) 
concluded, as a consequence of clients not being well informed of risks within the first 
five sessions of therapy, consent to psychotherapy was deemed insufficient.  Pomerantz 
(2005) surveyed licensed psychologists regarding the timing of informed consent; they 
asked what the psychologists felt, specifically, was the earliest point in time at which they 
could provide information regarding specific aspects of therapy, including risks and 
alternatives.  The general consensus among psychologists include requiring “about one 
full session of psychotherapy to feel capable of addressing the many important aspects of 
psychotherapy” including risks (Pomerantz, 2005, p. 356).  In another study Sullivan, 
Martin, and Handelsman (1993), instructed participants to rate their initial impressions of 
therapists that use either oral or written informed consent procedures, including 
information related to risk or benefits of treatment, or of therapists that use no informed 
consent.  Participants gave higher ratings to those therapists who used an informed 
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consent procedure and were more willing to recommend the therapist to a friend and go 
to him or her for therapy (Sullivan et al., 1993).  Psychology professionals who used an 
informed consent procedure were rated as more “expert and trustworthy” then those who 
did not (Sullivan et al., 1993, p. 160).  
Informed Consent Biases 
 Knapp and VandeCreek (2006) assert that the “standards of informed consent 
were developed primarily from physical medicine or surgery, and the degree to which 
they apply to mental health treatment is controversial” (p. 100).  As one of the most 
arguable components of informed consent, the APA's Code of Ethics (2002) briefly 
mentions the ethical need to inform clients of the benefits and risks of treatment. 
Although this is a clear standard of practice when psychotropic medications are involved 
(due to pharmacological side effects), it is less clear when it comes to psychotherapy. 
Plaut (1989) notes “the apparent trade-off between, on one hand, increased autonomy, 
reduced dependency and increased participation by the patient and, on the other hand, 
decreased trust in the physician, is a difficult one” (p. 436), and continues to produce 
ethical dilemmas for clients, psychologists and attorneys.  Although “informed consent is 
not an optional process,” Braaten, Otto, and Handelsman (1993) reveal “client 
preferences are not the final determining factor in what information psychologists 
provide” (p. 569).  These authors reveal that “the fundamental functions of informed 
consent, to promote individual autonomy and to encourage rational decision making are 
paramount” and “psychologists need to follow the disclosure guidelines mandated by 
ethics codes and state laws” (p. 569), Braaten et al. (1993) conclude that if the 
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psychological profession follows only what is “absolutely required they may be missing 
the opportunity to provide the most good for clients” (p. 569). 
 Ethicists and researchers agree that informed consent is at the core of moral 
practice in both medicine and treatment; however, it may be perceived as less important 
in clinical practice settings then in treatment setting for a several reasons (Pellegrino & 
Thomasma, 1993).  Practicing psychologists may have a limited understanding of the 
informed consent process because they have insufficient training for providing fully 
informed consent (Walker et al., 2005).  There may also be an attitude bias among 
psychologists toward the client's level of competence to give accurate, informed consent 
to engage in psychotherapy.  For example, the literature on competence tends to focus 
more closely on severe mental illness impairment (i.e. mental retardation, dementias, 
severe cognitive impairment); depending on the circumstances, these impairments could 
make it difficult for clients to give their full consent to psychotherapy (Grisso & 
Appelbaum, 1998; Elliott, 1997).  According to Grisso and Appelbaum (1998), the 
criteria for a client to make an informed decision include the ability to express his or her 
choice, understand relevant information, appreciate the significance of the situation and 
the choices, and reasonably weigh options (see also Historical Factors of Informed 
Consent).  In research, however, clients with depressive disorders (with the exception of 
psychotic depression) are typically considered competent to give consent to undergo 
research involving medical treatments (Appelbaum, Grisso, O’Donnell, & Kupfer, 1999). 
In their study of moderately depressed, outpatient women with major depressive disorder, 
Appelbaum et al. (1999) found participants “performed quite well on a measure of their 
decision-making capacities related to research” (p. 1383).  These authors note that few 
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participants “manifested difficulties with understanding, appreciation, or reasoning to a 
degree that would raise suspicions about their capacity to make an informed choice...the 
extent of depressive symptoms did not seem to affect the level of performance” 
(Appelbaum et al., 1999, p. 1383).  Researchers find that participants who suffer from 
severe mental illness (i.e., schizophrenia and bipolar disorder) have also been found 
competent to understand and retain informed consent information; however, when 
compared with medically ill participants, they are reported to have less understanding of 
consent information (Flory & Emanuel, 2004; D. Wirshing, W. Wirshing, Marder, 
Liberman, & Mintz, 1998).  In clinical practice settings, an individual entering into 
psychotherapy should be thought of as being able to understand and to give their fully 
informed consent to treatment, regardless of their subsequent mental illness or current 
diagnosis, as defined in the APA Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV-TR).  
 Meisel, Roth, and Lidz (1977) indicate that “if all risks and possible consequences 
of the procedure in question, and all alternative procedures are presented to the patient 
and the patient has given evidence that the presentation was understood” then consent is 
thought to be informed (as cited in Widiger & Rorer, 1984, p. 508).  However, some 
authors recount that it may not always be appropriate to disclose all relevant and 
important information when a client, according to Morse (1967), is experiencing 
“instability, distress, [and] confusion” (as cited in Widiger & Rorer, 1984, p. 508).  
Meisel et al. (1977) note, “if disclosure of certain information-especially the risks of 
treatment is likely to upset the patient so seriously that he or she will be unable to make a 
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rational decision, then the physician has the 'therapeutic privilege' to withhold such 
information” (p. 282).  
 Other potential biases regarding informed consent implementation, according to 
Braaten and Handelsman (1997), include therapist's concern over the impact on the 
therapeutic relationship, the client's view of the therapist's ability to help him or her, 
resulting in the possibility of client drop-out.  These authors suggest that because the 
modal length or therapy is one session (Talmon, 1990), and studies reveal drop-out rates 
for psychotherapy to be within the first three to five sessions (Garfield, 1986), therapists 
may not be presenting adequate “useful information at the beginning of counseling” 
(Braaten & Handelsman, 1997, p. 313).  However, the “promotion of autonomy and 
rational decision making is thought to enhance and help define the relationship between 
client and therapist” (Braaten & Handelsman, 1997, p. 312); it should not negatively 
impact it. 
 Beahrs and Gutheil (2001) recommend an integration of clinical aspects of 
informed consent along with the legal requirements; this might be done verbally, with 
documentation of the client's “level of interest and understanding in the written record” 
(p. 8).  Although the written consent meets, more closely, a legal criterion, Beahrs and 
Gutheil (2001) assert “written contracts with patients run the risk of sacrificing clinical 
rapport so essential to positive therapeutic outcome and fail to address new questions that 
emerge” (p. 8).  Although the “burden of the therapist to provide informed consent varies 
with the particular client, the clinical problem at hand, and the social context”, Beahrs 
and Gutheil (2001) assert, “these burdens increase directly with the costs and risks of the 
recommended treatment” (p. 8).  Beahrs and Gutheil (2001) note that regardless of how 
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“the process is implemented, it is important that patients understand that multiple options, 
including no treatment exist - each with different rationales, methodologies, and 
risk/benefit profiles” (p. 8).  
 There are no guarantees that all clients will fully comprehend and understand 
potential negative effects of psychotherapy; however, having clinical guidelines for 
informed consent would help ensure clients and therapists be provided with the best 
available knowledge of these matters.  Boisvert and Faust (2003) note “if therapists are 
unfamiliar with the domain of knowledge in psychotherapy research, the information 
provided on these types of matters [negative treatment effects] pertaining to informed 
consent is likely to be personal opinion and may not align with the research evidence” (p. 
512).  Similarly, “if a therapist's views deviate from consensus opinion among experts, 
clients should be informed of both positions and the strength of the evidence on which 
each rests” (Boisvert & Faust, 2003, p. 512).  Ensuring that the client gives truly 
informed consent for psychotherapy is an essential part of psychologists fulfilling the 
ethical obligations and legal requirements of informed consent.   
 Approximately 400 studies in the last decade have addressed information on 
informed consent (Sugarman et al., 1999).  However, a review of informed consent 
literature related to risk reveal that there have been few published studies related to 
psychologists informing clients of potentially negative effects of psychotherapy during 
informed consent processes.  All the previously mentioned studies looked at the problem 
of negative treatment effects, general informed consent procedures, and information 
related to what clients and clinicians considered important.  There is a need to survey 
doctoral-level, licensed psychologists on negative treatment effects and to inquire how 
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they practice fully informed consent.  This current survey study has intended to assess 
licensed psychologists’ attitudes toward and practices pertinent to, addressing negative 
effects of psychotherapy during informed consent process.  Because of the considerable 
research on negative effects of psychotherapy, licensed psychologists were surveyed on 
attitudes and subsequent practices toward these negative treatment effects related to 
informed consent practices.  
 It has been hypothesized that addressing negative effects of psychotherapy during 
informed consent may have negative implication for treatment.  In their study, Braaten 
and Handelsman (1997) surveyed patients, former patients, and non patients on attitudes 
toward informed consent and the importance of being informed about the risks of 
psychotherapy.  These researchers found former clients “placed more of an emphasis on 
risk of counseling than did one or more of the other groups, possibly because they had 
more experience with some of the potential problems inherent in counseling” (p. 323). 
These authors point out “that although it has been suggested that clinicians may withhold 
information about treatment risks because of concerns about potential negative effects on 
clients (Handelsman et al., 1986; Noll & Haugen, 1985), people who have been through 
the therapy process value the information” (p. 323).  Jensen et al. (1991) point out those 
psychotherapists might “curtail disclosure about therapeutic risks, fearing such 
information might deter potential clients from engaging in therapy” (p. 168).  This 
“attitude,” the authors reveal, “may particularly reflect clinicians' tendencies to 
systematically underestimate the importance of discussion of certain issues, particularly 
therapeutic risks, in informed-consent contexts” (Jensen et al., 1991 p. 168).  The authors 
note that some potential psychotherapy clients might “not only tolerate this type of 
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discussion, they might welcome such disclosure” (Jensen et al., 1991 p. 168).  Other 
studies suggest that consumers of psychotherapy value a risk-benefit discussion, even if 
the information disclosed is not necessarily used in their treatment decisions (Denney, 
Williamson, & Penn, 1976; Faden & Beauchamp, 1980; Gustafson, 1988).  
 Informing clients of the potential risks of engaging in psychotherapy, including 
the fact that treatment might not work for everyone, is a fundamental part of obtaining 
truly informed consent.  The potential risks of negative treatment effects (including 
iatrogenic and deterioration effects) might appear initially less severe with talk therapies; 
however, they are just as important as the potential risks of psychopharmacological side 
effects.  Informing clients in full regarding risks and benefits to treatment, not only gives 
them the option of choice, but it also helps them recognize the importance of being part 
of their own treatment and therapy.  More information is necessary in order to understand 
how psychologists comprehend and implement informed consent in their own 
psychotherapy practices.  Although it is clear that most psychologists receive education 
on ethics and informed consent in graduate school and post-doctoral studies, guidelines 
that outline the application of the Ethics Code (2002) appear vague and incomplete.  
More research is sorely needed so that psychologists may better understand these issues 
in clinical practice.  Because there is such little information on the clinical practice 
related to addressing potential negative treatment effects of psychotherapy during the 
process of informed consent, this survey study is somewhat exploratory. 
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Chapter Three: Hypotheses 
Specific Hypotheses and Questions  
 The research question for this study was based on informed consent research and 
theory from the past several decades (e.g., Bergin, 1971; Strupp et al., 1977; Mohr, 1995; 
Stricker, 1995; Boisvert & Faust, 2003; APA, 2002), establishing the notion of informing 
clients of potential risk as being integral to the informed consent process.  The informed 
consent doctrine mandates that discussion of potential negative effects directly resulting 
from psychotherapy is a necessary component of informed consent (Jensen et al., 1991). 
The hypotheses for this survey study presume that licensed psychologists obtain, at some 
point prior to beginning psychotherapy, informed consent from their potential clients.  A 
relative standard of disclosure and lack of specific clinical guidelines regarding informed 
consent indicate a need for research investigating the attitudes and practices of currently 
licensed psychologists.  Empirically supported, informed consent is currently 
recommended for psychotherapy; however, the question of informing clients as part of a 
discussion of risks, potential negative effects associated with psychotherapy, remains 
unclear.   The following research hypothesis was proposed: 
 Hypothesis 1.  Licensed psychologists who acknowledge the significance of 
potential negative effects associated with psychotherapy are more likely to inform their 
clients of risks associated with negative treatment effects.  
 Rationale.  Research findings suggest there appear to be similarities in the 
reported ethics and belief systems of psychotherapists and their subsequent practices 
(Somberg, Stone, & Claiborn, 1993; Pope, Tabachnick, & Keith-Spiegel, 1987). 
Therefore, licensed psychologists who endorse congruent scores on the survey related to 
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the occurrence of negative treatment effects as a result of psychotherapy are expected to 
subsequently inform clients of potential risk regarding negative treatment effects.  
 Hypothesis 2.  The second area of investigation posed the question: Are licensed 
psychologists hesitant to address negative effects of psychotherapy due to the belief that 
it will negatively impact the therapeutic alliance and subsequent psychotherapy outcome?  
It was hypothesized that licensed psychologists will rate the addressing of potentially 
negative treatment effects associated with psychotherapy as less important if they believe 
that it will negatively affect the therapeutic alliance and psychotherapy outcome. 
 Rationale.  Braaten and Handelsman (1997) discuss potential biases that 
psychologists hold relative to informed consent implementation.  There is concern among 
practicing psychologists relative to addressing potential negative effects of 
psychotherapy, concerning how this might impact the therapeutic relationship, the client's 
view of the therapist's ability to help him or her, and subsequent client drop-out (Braaten 
& Handelsman, 1997).  Braaten and Handelsman (1997) note that providing useful and 
relevant information at the beginning of the informed consent process may improve 
psychotherapy outcome.  Research reveals a discrepancy concerning what clients and 
clinicians rate as important information to be included during informed consent. In their 
study of parents seeking therapy for their children, Jensen et al. (1991) revealed that 
therapists rated a discussion of informed consent issues, particularly therapeutic risks, 
less important than did parents.  Therefore, it is expected that licensed psychologists who 
endorse greater risk of negatively impacting the therapeutic alliance and subsequent 
treatment outcome, will be less likely to inform clients of potential negative effects of 
psychotherapy, during informed consent. 
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 Hypothesis 3.  The third area of investigation poses the question:  Are certain 
demographic characteristics (degree, theoretical therapeutic orientation, career setting, 
clinical experience, and post-doctoral ethics training) among licensed psychologists 
related to attitudes and/or practices of informed consent procedures?  It was hypothesized 
that the number of years of clinical experience, post-doctoral ethics training, and a 
Cognitive-Behavioral orientation, would positively correlate with licensed psychologists’ 
attitudes regarding the importance of including risks of potential negative effects of 
psychotherapy during the informed consent process. 
 Rationale.  Psychologists who have more experience in the practice of 
psychology are also presumed to have more contact with clients and subsequent ethical 
situations.  Similarly, those psychologists who have attended post-doctoral ethics training 
are presumed to have received information on the process of informed consent and 
disclosure of risks.  The Cognitive-Behavioral orientation lends itself toward encouraging 
autonomy in their clients.  In fact, Somberg et al. (1993) revealed in their study 
“therapists of a Cognitive-Behavioral orientation indicated they inform clients more often 
and consider the issues more important” than therapists from other therapeutic 
orientations (p. 153).  With such a strong emphasis on the client’s taking an active role in 
treatment, it seems that psychologists whose primary orientation is Cognitive-Behavior 
Therapy (CBT) would be more likely to encourage client participation in a discussion of 
risks during the process of informed consent.  However, whether or not licensed 
psychologists from a CBT orientation inform clients of potential risks of negative 
treatment effects as a result of psychotherapy, during the process of informed consent, 
remains unknown.  
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Chapter Four: Method 
Overview 
 The present study focused on licensed psychologists' attitudes and practices 
related to addressing potential negative effects of psychotherapy during the informed 
consent process.  This research study included a nationwide sample of licensed 
psychologists' attitudes and practices toward many of the issues raised in the literature 
regarding risk and the ethical implementation of informed consent procedures. 
Design and Design Justification 
 A survey research design strategy was used for the proposed investigation.  No 
identifying information was collected.  The study utilized a survey-based research design 
(questionnaire format) in order to assess licensed psychologists’ attitudes and practices 
related to addressing potential negative effects of psychotherapy during the informed 
consent process. 
Data Reporting and Entry.  The survey questionnaire utilized a Likert-type 
scale. Responses were placed in a numerical format for analysis.  All data from 
completed on-line survey questionnaires using SurveyMonkey were subsequently entered 
into a spreadsheet database for final analysis, using Statistical Software for the Social 
Sciences (SPSS 16.0).  Descriptive statistics were examined including frequency, 
distribution, mean, median, standard deviation, and standard error.  A correlational 
analysis (using a Pearson product-moment correlation coefficient) was the preferred 
means to determine the relationship between general attitudes toward negative treatment 
effects of psychotherapy and addressing those risks during the process of informed 
consent.  Between-group comparisons were conducted by means of one-way analyses of 
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variance (ANOVA) in order to assess for group differences.  An analysis was conducted 
on demographic data in order to ascertain correlations on attitudes regarding informed 
consent practices and negative treatment effects. 
Participants 
 The nationwide sample consisted of 161 completed surveys from licensed 
psychologists.  Qualified participants included male and female licensed psychologists, 
defined as mental health professionals who apply scientifically validated procedures to 
help people change their thoughts, emotions, and behaviors (APA, 2008).  For the 
purposes of this study, psychotherapy, according to the APA (2008) was defined as, 
“treatment of emotional or behavioral problems by psychological means” (p. 1-5).  It 
includes a collaborative effort between an individual and a psychotherapist and provides 
a supportive environment to talk openly and confidentially about concerns and feelings. 
For this study, psychologists were included in this sample provided they were: 1) licensed 
to practice psychology in the state where they practice or in some other state; 2) hold a 
Doctoral degree in a mental health related field, and 3) have an available electronic mail 
address.  
 Notice for participant recruitment was sent out through electronic mail obtained 
on various websites over the World Wide Web; these included:  National Directory of 
Psychologists, The Association of Black Psychologists, and graduate school psychology 
programs listed on the APA directory.  Participation in this study was on a voluntary 
basis.  Participants gave consent by choosing to accept the prompt NEXT at the 
beginning of the on-line questionnaire presented in Appendix A and B.  Participants in 
the study were free to withdraw from the study for any reason, at any time and were 
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treated in accordance with the Ethics Code (2002).  Participants were excluded if they 1) 
did not hold a Doctoral level degree, 2) were not licensed to practice psychology in a 
state where they practice or in some other state, and 3) did not have an available 
electronic mail address.  
Measures 
 The instrument used in this survey study was a questionnaire developed 
specifically for this study, designed to capture attitudes and practices that licensed 
psychologists hold regarding informed consent practices, specifically related to risks of 
informing clients of potential negative effects of psychotherapy.  The survey included 
definitions from research regarding potential risk of negative effects (iatrogenic and 
deterioration effects) attributable to psychotherapy.  These definitions included:  no 
positive meaningful change, worsening of a symptom/condition, appearance of new 
symptoms, heightened concern regarding existing symptoms, excessive dependency on 
therapists, reluctance to see future treatment, the abuse or misuse of psychotherapy by the 
client, the client “overreaching” himself or herself , and physical harm (Lilienfeld, 2007; 
Boisvert & Faust, 2003; Nolan, 2004; Mercer, Sarner, & Rosa, 2003).  The questionnaire 
consisted of 27 questions in total.  The initial section of the questionnaire included self-
report questions (dependent variables) on attitudes and practices related to informing 
their clients of potentially negative treatment effects during the informed consent process. 
The latter portion of the survey included demographic characteristics (independent 
variables):  (a) gender, (b) age, (c) ethnicity, (d) number of years working as a licensed 
psychologist, (e) populations served, (f) practice location, (g) theoretical therapeutic 
orientation, and (h) post-doctoral ethics training, etc.  These variables have been studied 
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in relation to a variety of ethical issues (e.g., Borys & Pope, 1989; Pope, Tabachnick, & 
Keith-Speigel; Somberg, Stone, & Claiborn, 1993).  Responses on the questionnaire were 
rated by using a response key on a 7-point Likert scale (i.e., Strongly Agree=1, to 
Strongly Disagree=7; and Very Unimportant=1, to Very Important=7), true of false, and 
options from a drop down menu.  
Procedure 
 After an extensive literature review (conducted using PsycINFO) on informed 
consent and psychotherapy, it became apparent that there was a significant gap in both 
the research and clinical literature related to the clinical implementation of informed 
consent procedures using the APA’s Ethics Code.  Although studies on informed consent 
and risk are available, addressing potential negative effects as a result of engaging in 
psychotherapy did not appear to be emphasized.  Further, there are limited guidelines and 
implementation procedures, about when or how to inform clients of potential negative 
effects as a result of psychotherapy.  Research is lacking relative to information on 
practicing psychologists’ attitudes regarding their own informed consent procedures, and 
relative to whether or not they address potential negative effects as a result of some 
aspect of psychotherapy with their clients. 
 The questions on the survey were chosen in order to capture licensed 
psychologists’ attitudes and practices of the informed consent process, specifically 
related to potential negative effects as a result of psychotherapy.  Participants were 
instructed to respond to the survey questions regarding each of the 27 items.  The next 
step was to pilot the questionnaire on a small number of psychology faculty at the 
Philadelphia College of Osteopathic Medicine (PCOM).  The questionnaire was 
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examined for clarity, grammatical errors, and order of questions.  Efforts were made to 
enhance the presentation, the attractiveness, and the appeal of the questionnaire, because 
this has been found to entice the respondent to complete it (Dommeyer, 1988).  In 
addition, both positively and negatively worded items were included to eliminate 
potential acquiescence bias (Smyth, Dillman, Christian & Stern, 2007; Nunnally & 
Bernstein, 1994).     
 Surveys were distributed to 2,148 currently licensed psychologists through 
professional psychological associations and societies using their electronic mail address; 
through this method, 161 completed surveys were obtained.  The electronic mail included 
a brief description of the study and website address that directed potential participants to 
the questionnaire on SurveyMonkey over the World Wide Web (Appendix A).  The 
participants were able to give their consent to participate in the study by clicking on the 
NEXT button at the beginning of the on-line questionnaire.  No personal identifying 
information was collected and steps were taken to protect participant’s anonymity.  
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Chapter Five: Results 
A nationwide sample of 2,148 potential participants was solicited through their 
electronic mail address to participate in the survey.  A total of 161 doctoral level 
psychologists chose to participate in the study.  The overall response rate was 7.5% for 
completed on-line questionnaires.  The survey contained a total of 27 items.  The initial 
part of the survey contained questions related to licensed psychologists' attitudes and 
practices of obtaining informed consent, specifically related to addressing potential 
negative treatment effects of engaging in psychotherapy (Appendix B).  These first 14 
questions were measured through various scales including a seven-point Likert scale; this 
was coded from 1 to 7 on agreement (Strongly Agree=1, Moderately Agree=2,  Slightly 
Agree=3, Neutral=4, Slightly Disagree=5, Moderately Disagree=6, Strongly Disagree=7), 
and 1 to 7 on importance (Very Unimportant=1, Moderately Important=2,  Slightly 
Unimportant=3, Neutral=4, Slightly Important=5, Moderately Important=6, Very 
Important=7), Yes or No, and last, by picking an option from a list of multiple choice 
items.  The second half of the questionnaire captured demographic information from 
participants.  The latter portion contained 13 questions coded on a multiple choice or 
drop down menu format.  Every item on the survey questionnaire was calculated for 
percentages. 
Demographic Information on the Study Sample 
 The majority of the sample was Caucasian (90.2%) and evenly split between 
males (49.6%) and females (50.4%).  The age of the participants varied, with 26.7% 
between the ages of 59 and 74, 38.3% between the ages of 44 and 59, and 35.0% between 
the ages of 31 and 44.  The majority of the participants hold a Ph.D. degree (82.8%), with 
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the rest possessing a Psy.D. degree (15.7%) and Ed.D. degree (1.5%).  The majority of 
participants have a primary emphasis in clinical psychology (85.1%), with the rest 
endorsing counseling (7.5%), and other (7.4%) areas of emphasis.  The most frequently 
endorsed orientation was Cognitive/Behavioral (46.9%), with Psychodynamic (16.9%) 
and Interpersonal (13.1%) following next.  The least endorsed orientation was the 
Behavioral (10.0%); the rest endorsed other areas of emphasis (13.1%).  Most of the 
participants (93.9%) do not hold an American Board of Professional Psychology (ABPP) 
specialty certificate.  The majority of the sample has practical experience working with 
an adult (75.8%) and older adult (28.9%) population, with adolescent (44.3%) experience 
next and working with the child (28.2%) population somewhat less frequently.  It should 
be noted that participants were able to endorse more than one population.  The most 
frequent therapy modality reported was with individual (76%) clients, with families 
(10.1%), groups (8.5%); couples (54%) was rated less frequently.  It should be noted that 
participants were able to choose more than one modality; however, 32 participants chose 
not to answer the question.  Half of participants (50.4%) reported primary work in 
academic settings (college or university), with solo independent practices (41.4%) rated 
next, group practices (12.0%); research (10.5%) was somewhat less frequent and 
community mental health centers (8.3%) and hospital setting (8.3%) were the least 
frequently reported.  It should be noted that participants were able to pick more than one 
modality and 28 participants chose not to answer the question.  Participant work 
experience in the field of psychology is categorized into three groups: more than 30 years 
(20.2%), 5 to 10 years (23.4%), and 11 to 15 years (16.9%).  The demographic data 
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obtained are similar to results obtained from a nationwide survey (see page 90).  (Table 1 
presents the demographic characteristics in detail.) 
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Table 1 
Demographic Characteristics of the Sample 
________________________________________________________________ 
Demographic                Percentage 
________________________________________________________________ 
Gender 
 Male     50.4 
 Female    49.6 
Ethnicity 
 Caucasian    90.2 
 African American     2.3 
 Hispanic      2.3  
 Native American     0.8 
 Asian/ Pacific Islander    2.3 
 Multi-Racial      2.3      
Education 
 Ph.D.     82.8 
 Psy.D.     15.7 
 Ed.D.       1.5 
ABPP* 
 None     93.9 
________________________________________________________________ 
*American Board of Professional Psychology specialty certificate 
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Table 1-cont. 
Demographic Characteristics of the Sample 
________________________________________________________________ 
Demographic                Percentage 
________________________________________________________________  
Age 
 Between age 59- 74   26.7 
 Age 44 – 58     38.3 
 After age 31 – 44    35.0 
Doctoral Degree Emphasis 
 Clinical    85.1 
 Counseling      7.5 
 Developmental     3.0 
 Educational      1.5 
 School       2.2 
            Social       0.7 
Orientation 
 Cognitive/Behavioral   46.9 
 Behavioral    10.0 
 Psychodynamic   16.9 
 Interpersonal    13.1 
 Systems    13.1 
________________________________________________________________ 
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Table 1-cont. 
Demographic Characteristics of the Sample 
________________________________________________________________ 
Demographic                Percentage 
________________________________________________________________  
Primary Population Served* 
 Child     28.2 
 Adolescent    44.3 
 Adult     75.8 
 Older Adult    28.9 
No. Years Working in Psychology 
 Less than 5 years     4.8 
 5 to 10     23.4 
 11 to 15    16.9 
 16 to 20      9.7 
 21 to 25    13.7 
 26 to 30    11.7 
 More than 30 years   20.2 
________________________________________________________________ 
*Participants were able to rate more than one choice. 
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Table 1-cont. 
Demographic Characteristics of the Sample 
________________________________________________________________ 
Demographic                Percentage 
________________________________________________________________  
Therapy Modality* 
 Individual    76.0 
Family     10.1 
Group       8.5 
Couple      54.0 
Primary Work Setting* 
 Academia     50.4 
 Solo Independent Practice  41.4 
 Research    10.5 
 Community Mental Health    8.3 
 Group Practice   12.0 
 Hospital      8.3 
 Treatment facility     2.3 
 School       2.3 
 Correctional facility     1.5 
 Administration     1.5   
________________________________________________________________ 
*Participants were able to rate more than one choice.  
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Frequent Attitudes Endorsed in the Study Sample 
Data describing attitudes related to informed consent practices, specifically 
toward potential harm from engaging in psychotherapy, include the following:  general 
ethics and informed consent practices, risks and potential negative treatment effects, 
therapeutic treatment techniques, clinical judgment, negative patient/client reactions, 
alternative treatment procedures/techniques, and methods frequently used for obtaining 
informed consent. (Tables 2, 3, 4, and 5 present psychologists’ attitudes in detail.). 
Descriptive statistics that demonstrated commonly endorsed attitudes and practices 
related to addressing negative treatment effects of psychotherapy during informed 
consent are as follows:   
An overwhelming majority of participants (97.1%) agreed that there are potential risks to 
clients in engaging in psychotherapy (Strongly Agree=24.3%, Moderately Agree=34.0%, 
and Slightly Agree=36.1%).  It should be noted that 12 participants chose not to answer 
this question.  However, they completed the remaining demographic questions; therefore, 
they were retained in the study.  Similarly, the majority of participants (90%) agreed that 
some psychotherapeutic treatment techniques produce a greater probability of potentially 
negative treatment effects than others (Strongly Agree=35.7% and Moderately 
Agree=38.6%).  Participants’ attitudes related to the use of clinical judgment (evoking 
therapeutic privilege) toward negative treatment effects were somewhat varied, with one-
half (50%) reporting disagreement with its use and significantly less (23.1%) in 
agreement (Moderately Disagree=26.9%, Strongly Disagree=23.1% and Slightly 
Agree=15.7%, Moderately Agree=6.7%, Strongly Agree=0.7%).  A small portion 
(14.9%) remained neutral and 23 participants chose not to answer the question.  More 
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than one-half of the participants (66.9%) reported no known negative reactions from 
clients, relative to the informed consent process as a whole (Strongly Disagree=40.4%, 
Moderately Disagree=26.5%).  Twenty-one participants chose not to answer the question.  
More than half (68.6%) of participants agreed that addressing potentially negative 
treatment effects of psychotherapy during the informed consent process does not 
negatively impact the therapeutic alliance and subsequent treatment outcome (Strongly 
Agree=34.3%, Moderately Agree=34.3%, and Slightly Agree=12.4%).  Twenty 
participants chose not to answer the question.  The majority of participants (89.4%) 
agreed that a discussion of the risk, including potentially negative treatment effects 
during informed consent, is of ethical importance (Of note, this was a negatively worded 
question) (Strongly Disagree=69.9%, and Moderately Disagree=19.5%).  Twenty-four 
participants chose not to answer the question.  The majority of participants disagreed 
(53%) and a somewhat fewer number agreed (39.5%) that symptomology, personality, 
and overall functioning impacts the therapeutic decision to address negative treatment 
effects in psychotherapy (Strongly Agree=6.7%, Moderately Disagree=13.4%, Slightly 
Agree=19.4%, and Strongly Disagree=19.4%, Slightly Disagree=20.9, Slightly 
Disagree=12.7%).  Twenty-three participants chose not to answer the question.  
Similarly, participants’ attitudes were almost evenly split (48.6% endorsing disagreement 
and 43.8% noting agreement) regarding informing clients at the onset of psychotherapy, 
that therapy might not work for them and that they could become worse as a result of 
engaging in psychotherapy (Strongly Agree=5.4%, Moderately Agree=14.6%, Slightly 
Agree=23.8%, and Slightly Disagree=16.2%, Moderately Disagree=16.2%, Strongly 
Disagree=16.2%).  Twenty-seven participants chose not to answer the question.  
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Interestingly, of 161 responses to the statement, “10 percent of clients get worse as result 
of psychotherapy”, 41% endorsed a neutral attitude and 25 participants chose not to 
answer this question.  
 When asked how important it was to address potentially negative effects of 
psychotherapy during informed consent, almost half (48.3%) agreed about its importance, 
but significantly fewer (19.6%) did not (Very Important=28.0%, Moderately 
Important=23.1%, Slightly Important=18.2%, and Very Unimportant=10.5%, Moderately 
Unimportant=6.3%, Slightly Unimportant=2.8%). (See Table 2).  It should be noted that 
14 participants chose not to answer this question.  A discussion of alternative 
treatment/procedures (including no treatment) was rated important during informed 
consent by 41.2% participants, and somewhat less important by 18% of the sample (Very 
Important=28.0%, Moderately Important=24.5%, Slightly Important=14.7%, and Very 
Unimportant=9.8%, Moderately Unimportant=10.5%, Slightly Unimportant=7.7%). (See 
Table 3).  Fourteen participants chose not to answer this question.  Approximately one-
third (34.1%) of the sample reported beginning the discussion of informed consent prior 
to the first session of psychotherapy; more than half (58.0%) reported starting the 
discussion during the first session, and significantly fewer (6.5%) reported a discussion of 
informed consent on an as-needed basis or not at all.  Nineteen participants chose not to 
answer this question (See Table 4).  Finally, the most common methods of assessment for 
overall progress in psychotherapy include:  use of outcome measures and questionnaires 
(84.0%), asking the client directly (72.5%), and giving and receiving feedback (65.1%) 
(See Table 5 for details).  It should be noted that more than one category could be rated 
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for this question; therefore, some participants rated more than one method of assessment 
and 23 participants chose not to answer this question. 
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Table 2 
Frequent Attitudes Endorsed on the Survey Questionnaire 
________________________________________________________________ 
Attitudes                   Percentage 
________________________________________________________________  
There are potential risks to clients engage in psychotherapy. 
 Strongly Agree      24.3 
 Moderately Agree      34.0 
 Slightly Agree       36.1 
 Neutral           1.4 
 Slightly Disagree        0.0 
 Moderately Disagree        2.8 
 Strongly Disagree        1.4 
Some psychotherapeutic treatment techniques produced a greater probability of  
potential negative effects than others. 
 Strongly Agree      35.7 
 Moderately Agree      38.6 
 Slightly Agree       15.7 
 Neutral         4.3 
 Slightly Disagree       1.4 
 Moderately Disagree       4.3 
 Strongly Disagree       0.0 
________________________________________________________________ 
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Table 2-cont. 
Frequent Attitudes Endorsed on the Survey Questionnaire 
________________________________________________________________ 
Attitudes                   Percentage 
________________________________________________________________  
There are times when my judgment about a client prevents me from addressing  
negative effects of psychotherapy during the informed consent process.  
 Strongly Agree        0.7 
 Moderately Agree        6.7 
 Slightly Agree       15.7 
 Neutral       14.9 
 Slightly Disagree      11.9 
 Moderately Disagree      26.9 
 Strongly Disagree      23.1 
My clients have reacted negatively during the informed consent process.  
 Strongly Agree        0.0 
 Moderately Agree        2.2 
 Slightly Agree         9.6 
 Neutral       12.5 
 Slightly Disagree        8.8 
 Moderately Disagree      26.5 
 Strongly Disagree      40.4 
________________________________________________________________ 
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Table 2-cont. 
Frequent Attitudes Endorsed on the Survey Questionnaire 
________________________________________________________________ 
Attitudes                   Percentage 
________________________________________________________________  
Addressing potential negative effects of psychotherapy during the informed consent 
process does not negatively impact the therapeutic alliance and subsequent treatment 
outcome. 
 Strongly Agree      34.3 
 Moderately Agree      34.3 
 Slightly Agree       12.4 
 Neutral       10.2 
 Slightly Disagree        2.9 
 Moderately Disagree        2.9 
Strongly Disagree        2.9 
________________________________________________________________ 
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Table 2-cont. 
Frequent Attitudes Endorsed on the Survey Questionnaire 
________________________________________________________________ 
Attitudes                   Percentage 
________________________________________________________________ 
During the informed consent process, a client’s current symptomology, personality,  
and overall functioning, impacts whether or not to address potentially negative effects  
of engaging in psychotherapy. 
 Strongly Agree        6.7 
 Moderately Agree      13.4 
 Slightly Agree       19.4 
 Neutral         7.5 
 Slightly Disagree      12.7 
 Moderately Disagree      20.9 
 Strongly Disagree      19.4 
________________________________________________________________ 
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Table 2-cont. 
Frequent Attitudes Endorsed on the Survey Questionnaire 
________________________________________________________________ 
Attitudes                   Percentage 
________________________________________________________________ 
It is unethical to include a discussion of risk of potential negative effects of 
psychotherapy during the informed consent process. 
 Strongly Agree        0.8 
 Moderately Agree        0.8 
 Slightly Agree         0.0 
 Neutral         2.3 
 Slightly Disagree        6.8 
 Moderately Disagree      19.5 
 Strongly Disagree      65.9 
________________________________________________________________ 
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Table 2-cont. 
Frequent Attitudes Endorsed on the Survey Questionnaire 
________________________________________________________________ 
Attitudes                   Percentage 
________________________________________________________________ 
At the onset of therapy I always tell my clients not only the therapy might not work  
for them, but that they could become worse as a result of engaging in psychotherapy. 
 Strongly Agree        5.4 
 Moderately Agree      14.6 
 Slightly Agree       23.8 
 Neutral         7.7 
 Slightly Disagree      16.2 
 Moderately Disagree      16.2 
 Strongly Disagree      16.2 
Approximately 10% of clients get worse as a result of engaging in some aspects of 
psychotherapy. 
 Strongly Agree        2.3 
 Moderately Agree      12.1 
 Slightly Agree       13.6 
 Neutral       41.7 
 Slightly Disagree        9.1 
 Moderately Disagree      11.4 
 Strongly Disagree        9.8 
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Table 3 
Frequent Attitudes Endorsed on the Survey Questionnaire 
________________________________________________________________ 
Attitudes                   Percentage 
________________________________________________________________  
How important is it to you to address potential negative effects of psychotherapy  
during the informed consent process? 
 Very Unimportant      10.5 
 Moderately Unimportant       6.3 
 Slightly Unimportant        2.8 
 Neutral       11.2 
 Slightly Important      18.2 
 Moderately Important      23.1 
 Very Important      28.0 
How important is it to you to inform clients of alternative treatment/procedures 
(including no treatment) during the informed consent process? 
 Very Unimportant        9.8 
 Moderately Unimportant     10.5 
 Slightly Unimportant        7.7 
 Neutral         4.9 
 Slightly Important      14.7 
 Moderately Important      24.5 
 Very Important      28.0 
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Table 4 
Frequent Attitudes Endorsed on the Survey Questionnaire 
_______________________________________________________________  
Attitudes                   Percentage 
_______________________________________________________________  
At what point during the therapeutic process do you usually began a discussion  
of informed consent? 
 Before the First Session     34.1 
 During the First Session     58.0 
 During the Second Session       0.7 
 During the Third Session       0.7 
 After the Third Session       0.0 
 On an “As Needed” Basis       5.1 
 Never          1.2 
 
________________________________________________________________ 
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Table 5 
Frequent Attitudes Endorsed on the Survey Questionnaire 
________________________________________________________________ 
Attitudes                   Percentage 
________________________________________________________________   
What methods do you most commonly use to assess your patient/clients’ 
overall progress in therapy?* 
 Questionnaires      43.0 
 Outcome Measures/Assessments    51.0 
 Asking the Client      72.5 
 Giving and Receiving Feedback    65.1 
_________________________________________________________________ 
*Participants were able to rate more than one choice. 
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Results of Hypotheses Testing 
 It was predicted that licensed psychologists would be more likely to inform clients 
of risk associated with potentially negative treatment effects as a result of engaging in 
psychotherapy, if they acknowledge the significance of those negative effects.  The first 
hypothesis stated there would be a correlation between attitudes toward negative 
treatment effects and acknowledgement of the potential risks to clients involved.  A two-
tailed Pearson product-moment correlation was used.  Results failed to support this 
hypothesis as an inverse relationship, r(141) = -0.254, p < 0.01, two tailed, was found. 
Licensed psychologists are less likely to address negative treatments of psychotherapy if 
they acknowledge the existence of those risks.  
 It was also predicted that licensed psychologists might be hesitant to address 
potentially negative effects of psychotherapy due to the belief that it will negatively 
affect therapeutic alliance and subsequent therapy outcome.  The second hypothesis 
stated that attitudes toward addressing negative effects would be rated less important if it 
was perceived to adversely affect therapeutic alliance and subsequent treatment outcome. 
A one-tailed Pearson product-moment correlation revealed an inverse relationship, r(136) 
= -0.228, p < 0.01, one tailed.  Results failed to support this hypothesis because attitudes 
toward negative effects are rated as being important to address during informed consent; 
however, they are not thought to impact therapeutic alliance and treatment outcome 
negatively.  Further, there was an inverse correlation found relative to the importance of 
addressing potentially negative treatment effects of psychotherapy during informed 
consent and to informing clients of the potential of therapy ineffectiveness and/or 
becoming worse, r(128) = -0.283, p < 0.01, two tailed.  These results suggest a 
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discrepancy between attitudes toward informed consent procedures and implementation 
during the informed consent process. 
 The third hypothesis predicted that years of clinical experience, post-doctoral 
ethics training, and a Cognitive-behavioral orientation, respectively, would correlate with 
attitudes related to informed consent practices, specifically with regard to discussion of 
risks related to negative treatment effects.  
 Clinical experience and attitudes.  It was expected that years of clinical 
experience as a licensed psychologist would correlate with attitudes and practices related 
to addressing risk during informed consent; however, results of a two-tailed Pearson 
product-moment correlation revealed no significant findings.  
 Post-doctoral ethics training and attitude.  It was expected that those who 
received post-doctoral training in ethics and informed consent, would be more likely to 
include a discussion of risk of potentially negative treatment effects as part of informed 
consent practice.  A one-way between subjects analysis of variance (ANOVA), at the 
p<0.05 level, revealed a difference between the mean score of those who received post-
doctoral ethics training (M=1.95, SD=1.07) and mean score of those who did not 
(M=2.54, SD=1.47), F (1, 120) = 4.99, p = 0.027, in support of the hypothesis. 
Participants who received post-doctoral ethics training are more likely to agree that some 
therapeutic treatment techniques produce greater probability of risk of negative effects 
than others.  A marginally significant relationship was found, using a one-way between 
subjects analysis of variance (ANOVA), at the p<0.05 level, between mean score of those 
who received post-doctoral ethics training (M=6.65, SD=0.85) and mean score of those 
who did not (M=6.25, SD=1.11), related to attitude toward ethical importance of a 
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discussion of risk of potential negative treatment effects during the informed consent 
process, F (1, 119) = 3.70, p = 0.056.  Results suggest that those who receive ethics 
training are more likely to agree with the ethical importance of addressing negative 
treatment effects during informed consent.  
 Orientation and attitudes.  It was expected that therapeutic orientation, 
specifically Cognitive-behavioral orientation, would be related to attitudes and practices 
toward addressing negative treatment effects during informed consent; however, results 
of a one-way between subjects analysis of variance (ANOVA), at the p<0.05 level, 
revealed no significant findings.  Licensed psychologists from a Cognitive-behavioral 
orientation were no more likely to rate the importance of addressing negative treatment 
effects during informed consent than those from other therapeutic orientations.  
 Although no original hypothesis were made, a one-way between subjects analysis 
of variance (ANOVA), at the p<0.05 level, was run to find out if degree (Ph.D. versus 
Psy.D.), or if gender, and age were related to attitudes and practices of informed consent, 
specifically related to importance in addressing negative treatment effects as part of a 
discussion of risk.  
 Degree versus attitudes and practice.  A significant result was found between 
means of those who hold a Ph.D. degree (M=4.74, SD=2.07) versus Psy.D. degree 
(M=5.71, SD=1.61) in regard to attitudes and practices of informing clients of alternative 
treatment/procedures (including no treatment) during the process of informed consent, F 
(1, 129) = 4.18, p = 0.043.  Those licensed psychologists who hold a Psy.D. degree rated 
informing clients of alternative treatments/procedures (including no treatment), during 
the process of informed consent, as more important than those who hold a Ph.D. degree.  
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 Gender versus attitudes and practice.  A significant correlation was found 
between means for licensed psychologist males (M=2.19, SD=1.47) and licensed 
psychologist females (M=1.69, SD=1.68) related to attitudes and practices toward the 
initial discussion of informed consent in psychotherapy, F (1, 129) = 5.88, p = 0.017. 
Results suggest that licensed psychologist females are more likely to begin the discussion 
of informed consent before or during the first session, but licensed psychologist males 
begin the discussion between the first and second session of psychotherapy.  
 Age versus attitudes and practice.  Analysis for age and attitudes and practices 
of informed consent procedures revealed no significant findings, which suggests that a 
licensed psychologist’s age does not correlate with attitudes and practices related to 
informed consent practices.  
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Chapter Six: Discussion 
Summary of the Study Rationale 
 The current survey study investigated the relationship between attitudes and 
practices toward addressing risk of potential negative treatment effects of psychotherapy 
during the process of informed consent.  Because of the potential of psychotherapy to 
produce risks of negative treatment effects, there are implications in clinical practice for 
informed consent procedures (Bergin, 1971; Boisvert & Faust, 2003; Lambert & Ogles, 
2004; Lilienfeld; 2007; Mercer, Sarner, & Rosa, 2003; Mohr, 1995; Stricker, 1995; 
Strupp, Hadley, & Gomes-Schwartz, 1977).  The rationale for this study is rooted in the 
Ethics Code (2002), which includes broad guidelines for obtaining informed consent to 
psychotherapy, including informing clients early on of the dynamics of treatment, 
potential risks, and of alternative treatments that may be available.  Although the Ethics 
Code (2002) refers specifically to the importance of informed consent with treatments 
that lack evidence-based efficacy, it is ethically and morally consistent with the 
fundamental concepts of informed consent to include a discussion of potential risk of 
negative treatment effects associated with psychotherapy (Barden, 2001, Boisvert & 
Faust, 2003; APA, 2002).  It is known that clinical research tends to have more stringent 
criteria to abide by the Ethics Code (2002); however, little is known about practicing 
psychologists’ attitudes and subsequent clinical practices related to addressing risk of 
negative treatment effects.  Because research is not well developed in this area, a survey 
design was used for the study.  Further, the study intended to explore general questions 
related to ethics, attitudes and practices in addressing risks of potential negative treatment 
effects of psychotherapy, including whether or not alternative treatments and/or 
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procedures are used, during the process of informed consent.  The relationship between 
years of formal training, theoretical therapeutic orientation, and invoking therapeutic 
privilege (use of clinical judgment) during informed consent was also assessed.  Findings 
for the current study suggest that opinions and practices regarding the application of 
informed consent, specifically related to addressing potential risk of negative treatment 
effects associated with psychotherapy, vary with characteristics of licensed psychologists. 
This is the first study known to quantify the attitudes and practices of licensed 
psychologists on this subject.  Several significant findings were discovered from the data 
analysis.  
Demographic Information 
It is noteworthy that the demographic data obtained for the current survey study is 
a close match to a nationwide sample (N=272) of licensed practicing psychologists 
(Greenbury & Jesuitus, 2002).  In their survey study, primary ethnicity was Caucasian 
(93.2%), almost evenly split male (48.5%) and female (50.7%).  The majority held a 
Doctor of Philosophy degree (Ph.D.=77.5%, Psy.D.=13.9%, Ed.D.=0.04%), with primary 
emphasis in clinical psychology (50-57%), with counseling (4-7%) rated significantly 
less.  Both primary and secondary orientation included, Cognitive/Behavioral (57%), 
Interpersonal (14%), Psychodynamic (11%), and somewhat fewer, Behavioral (6.5%). 
Primary work setting included Human Services (70%) and Educational/School (15%).  
Finally, 93% reported that they did not hold an American Board of Professional 
Psychology specialty certificate (Greenbury & Jesuitus, 2002). Because the demographic 
information was closely matched to a national sample, it could be inferred that the results 
of this study are representative of practicing psychologists in the United States.  
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Relationship between Attitude and Practice    
 Research revealed that licensed psychologists, who recognize risks of potential 
negative treatment effects from engaging in psychotherapy, are less likely to address 
potential risk during the informed consent process.  These findings reveal a discrepancy 
between attitudes toward informed consent procedures and the implementation of 
informed consent practice.  It should be noted that potentially negative treatment effects 
occur as a result in engaging in psychotherapy and does not mean clinical incompetence. 
Although licensed psychologists in this study generally agreed that potential risk of 
negative treatment effects are important enough to be discussed during informed consent, 
there is little evidence to support adequate implementation into the clinical setting.  The 
majority of licensed psychologists shared similar opinions regarding the ethical 
importance of addressing negative treatment effects during the process of informed 
consent.  These congruent attitudes centered on the existence of potential risks of 
engaging in psychotherapy, and that there are some treatment procedures which have 
greater potential to produce negative treatment effects than others.  Contrary to 
expectation, discussion of potential risk of negative treatment effects were generally not 
thought to adversely impact therapeutic alliance and subsequent treatment outcome.  In 
the clinical setting, however, there is some variability among licensed psychologists' 
practices relative to addressing informed consent of potential risk.  Licensed 
psychologists did not rate invoking therapeutic privilege (using clinical judgment), 
potential deterioration effects and ineffective psychotherapy, personality factors and 
overall functioning as potential variables that affect therapeutic decisions to include a 
discussion of risk as part of informed consent.  These finding are supported by Pope, 
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Tabachnick, and Keith-Spiegel (1987) who discuss “self-reported behavioral norms are 
not the same as ethical standards” (as cited in Somberg, Stone, & Clairborn, 1993).  The 
apparent variability may be attributed to the complexity of factors which impact the 
process of obtaining informed consent for a specific issue.  The data does not support the 
notion that licensed psychologists practice in accordance with their attitudes toward 
addressing risk of negative treatment effects during informed consent.  This conclusion is 
not reflected in the literature on informed consent practices and ethical issues.  
A possible explanation for the discrepancy between attitudes toward informed 
consent procedures and implementation of informed consent practice might be related to 
vague guidelines outlined in the Ethics Code (2002).  Although the code is intended to be 
used as a guideline for standards and professional conduct, personal attitudes about ethics 
and implementation of informed consent practice appear to vary widely.  Because of 
ambiguous ethical guidelines, the addressing of potential risk during informed consent is 
susceptible to individual interpretation (Pomerantz, 1998).  Walker et al. (2005) note that 
informed consent with psychotherapy appears less clear, due to the nature of the consent 
process, which tends to take place over a period of time.  As a guiding principle, 
information that is material to the particular client’s decision is needed in informed 
consent discussions (Beahrs & Gutheil, 2001).  Although the level of detail varies 
depending on the costs, the risks of the proposed treatment, viable alternatives, 
professional acceptance and the fact that it is research-based, the question remains how to 
address “problematic or controversial psychotherapeutic trends that temporarily enjoy 
wide professional support” (Beahrs & Gutheil, 2001, p. 4).  Lack of clear and distinct 
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outlines for informed consent procedures related to addressing risks of negative treatment 
effects, may account for licensed psychologists’ contradicting views.   
There is another possible reason that licensed psychologists report that they agree 
with engaging in psychotherapy that has the potential to produce negative treatment 
effects, but do not include a discussion of risk during informed consent; this reason 
involves the limitations of humans as information processors and may suggest cognitive 
biases (e.g. Dawes, Faust, & Meehl, 1989; Lutz et al., 2006).  The potential biases may 
limit the degree to which clinicians can accurately assess whether or not client outcome 
will be a success or failure.  Another possible explanation may be that clinicians might 
simply not trust their clients’ decisions or abilities to make choices about 
psychotherapeutic treatment.  Twenty-three percent of surveyed licensed psychologists 
reported that they use clinical judgment (evoking therapeutic privilege) when addressing 
risk toward negative treatment effects.  There is, however, no known evidence to suggest 
that clients informed about risks of engaging in psychotherapy cannot make informed 
decisions about treatment (in the absence of clear incompetence) (Walker et al., 2005).  
In fact, Jensen and MacNamara (1991) suggest that disclosure about potential risks 
during informed consent appears to have no negative effect on client decision to engage 
in psychotherapy.  Similarly, Handelsman (1990) reported that there is no empirical 
evidence to support adverse effects as a result of informing clients about risk that is 
related to psychotherapy during informed consent.  In light of evidence-based practice, 
the Institute of Medicine (2001) states that the process of informed consent must include 
an “integration of best research evidence with clinical expertise and patient values” (p. 
146).  The process of informed consent is intended to combine clinical knowledge with 
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client participation, while assuming an ethical and moral obligation to provide a detailed 
explanation of potential risks of negative treatment effects.  Another key expectation for 
informed consent includes respect for autonomy and the fact that informed consent is 
considered an on-going process throughout the psychotherapy experience.  Walker et al. 
(2002) suggest that informed consent, at a minimum, must contain disclosure of potential 
risks and benefits and address particular recommended alternative treatment.   
 Contrary to expectation, no significant differences were found in regard to the 
extent that years of clinical experience, theoretical therapeutic orientation, and the age of 
those practitioners impact attitudes and practices related to addressing risk of negative 
treatment effects during informed consent.  Although research indicates that some 
orientations may lend themselves more closely toward informed consent than others, 
because they consider issues “more important” (e.g., CBT treatment possesses a highly 
structured manualized approach) (Somberg et al., 1993, p. 153), results from this survey 
revealed orientation does not impact the decision about whether or not licensed 
psychologists inform clients of potential risks in treatment.  This finding is supported by 
both Dsubanko-Obermayr and Baumann's (1998) and Tymchuk, Drapkin, Major-
Kingsley, Ackerman, Coffman, and Baum’s (1982) survey studies, both of which 
produced similar results.  The finding that years of clinical experience does not correlate 
with attitudes or practices of addressing potential risk during informed consent is 
similarly supported by Boisvert and Faust's (2003) study (see section Informed Consent 
and Risk).  
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Implications for Informed Consent Practice  
 In the clinical setting, a conversation of risk that is related to potentially negative 
treatment effects as a result of engaging in psychotherapy has received limited attention, 
but is nonetheless important on ethical and moral grounds (see Ethics Code, 2002).  On a 
practical level, these arguments for addressing risk have potential implications related to 
the conduct of clinical practice protocols.  According to the Ethics Code's (2002) 
informed consent standards, licensed psychologist should be given clinical guidelines. 
The specifics of “viable alternatives” and “their relative grounding in scientific data and 
professional acceptance” during a proposed treatment remains unresolved (Beahrs & 
Gutheil, 2001).  Risks and benefits are clearly discussed when psychotropic medications 
are prescribed, “due to pharmacological side effects”; however, Walker et al. (2005) 
noted that it is less the case with psychotherapy alone (p. 241).  Although potential risk 
from verbal therapies might appear to have less visible impact, research reveals they are 
considered just as important to include during informed consent, as are the potential 
medical risks (Walker et al., 2005; Berg et al., 2001).  As previously mentioned, Thyer 
and Myers (1998) assert that clients are entitled to information related to evidence-based 
psychological treatment.  However, as research has noted, even the most effective and 
efficacious psychotherapeutic treatments do not work for everyone, which emphasizes 
the importance of including a discussion of potential risk that is related to negative 
treatment effects during the informed consent process.  
 In order to assess treatment that is not working, Lambert and his colleagues 
(2003) studied client feedback in psychotherapy, including its impact on outcomes.  In 
order to detect improvement, prior to the beginning of each psychotherapy session, 
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feedback regarding therapy was elicited from the clients and subsequently compared with 
average progress made by similar norms (onset and symptom severity).  Results 
demonstrated that providing clinicians with feedback had beneficial effects on 
psychotherapy outcomes.  Lambert et al. (2003) reported sole reliance on pure clinical 
judgment to identify and make treatment decisions was insufficient.  One of the main 
reasons that client feedback had such a dramatic effect on outcomes, Lambert et al. 
(2003) assert, is that, without this information, psychotherapists seldom expect their 
clients to become worse.  Lambert et al. (2003) equated measuring client outcomes to 
having one’s blood pressure taken in medicine. Obtaining tangible mental health vital 
signs can be used as a gauge for psychotherapy.  Roth and Fonagy (2004) report the fact 
that therapists often ignore signs that clients are not benefiting from psychotherapy due to 
biases in thinking.  Tracking progress would be beneficial in ensuring psychotherapists’ 
awareness of outcomes.  In order to assess psychotherapy treatment, an awareness of 
informed consent and negative treatment effects is essential.  Teaching critical thinking 
and facts regarding psychological disorders is paramount (Lilienfeld, 2007).  Lilienfeld 
(2007) asserted that a careful understanding of biases and heuristics can impact and 
influence one’s judgment into thinking that certain techniques or treatments are working, 
when in fact they are not.  
 Results from this study could have potential implications, for example, in 
establishing better comprehensive, informed consent guidelines for practitioners.  Half of 
the participants surveyed, for example, either remained neutral or did not rate the survey 
question:  “Approximately 10 percent of clients get worse as a result of engaging in some 
aspect of psychotherapy” (See Table 2).  Although the reasons about why this particular 
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question was ignored are unknown, it could be argued that practitioners are unfamiliar 
with knowledge from psychotherapy research on potential risk of negative treatment 
effects in psychotherapy.  Thus, they may be relying on personal opinions rather than on 
evidence-based research.  It seems essential that in order to apply science to 
psychotherapy, an understanding of findings about research on negative treatment effects 
would be considered paramount to practical application.    
 Method for obtaining progress in psychotherapy.  The method most commonly 
used to inform clients of overall progress in psychotherapy was outcome measures and 
questionnaires.  The other methods reported were asking the client directly, and giving 
and receiving feedback.  The use of outcome measures and questionnaires have their 
advantages (documentation, standardization of treatment, fewer liability concerns); 
however, it is interesting that verbal communication was not in greater use.  The available 
empirical data suggest a combination of both verbal and written methods are best practice 
in assessing overall progress. 
 Timing of informed consent procedures.  Although approximately one-third of 
the participants reported starting a discussion of informed consent prior to the first 
session of psychotherapy, more than half reported starting the discussion during the first 
session, and significantly fewer reported a discussion of informed consent on an “as- 
needed” basis or not at all.  Interestingly, female licensed psychologists are more likely to 
begin the discussion of informed consent before or during the first session, but male 
licensed psychologists begin the discussion between the first and second sessions of 
psychotherapy.  Although early presentation of informed consent factors might be ideal, a 
conversation of risks related to negative treatment effects might argue for greater 
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flexibility.  In one study, Pomerantz (2005) surveyed licensed psychologists regarding the 
“earliest feasible point at which they could provide information regarding specific aspects 
of therapy” (p. 351).  Results found more substantial information, such as potential risks, 
could be presented only after some engagement in psychotherapy.  Reasons for 
participants informing clients on an “as-needed basis” or “not at all” are unclear.  If, 
however, a specific therapeutic treatment/procedure has not yet been identified, it seems 
premature to expect licensed psychologists to inform clients of potential risks of negative 
treatment effects as a result in engaging in psychotherapy.  Appelbaum, Lidz, and 
Meisel's (1987) process model of informed consent (see Chapter 2) would provide greater 
flexibility if it viewed the informed consent process as continuous throughout the entire 
course of psychotherapy treatment rather than as a one-time event.  Although this survey 
study did not inquire about the kind of model that licensed psychologists use, the answers 
themselves appear to be within the context of a one-time event model.  Similarly, 
although most of the sample agreed that it is important to address risk of potential 
negative treatment effects, the survey did not inquire about a time when those potential 
risks are initially presented.  
 Post-Doctoral Ethics Training and Attitudes of Risk.  Data from this study 
suggest licensed psychologists who report receiving post-doctoral ethics training are 
more likely both to agree that some therapeutic treatment techniques have greater 
probability of producing risk of negative effects than others, and to agree to the ethical 
importance of addressing potential risk of negative treatment effects during informed 
consent.  Results, however, did not find that those who reported having had post-doctoral 
ethics training were more likely to inform clients of potentially negative treatment 
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effects.  These findings are consistent with other research which suggests that there is 
little consistency between ethical decision-making and psychologists' attitudes toward 
training in ethics (Tymchuk et al., 1982).  Licensed psychologists may have a limited 
understanding of the importance of post-doctoral training in ethics as it relates to 
informed consent practices that subsequently impact clients engaging in psychotherapy. 
Researchers strongly believe that it is important for clinical practice to be influenced by 
outcome research; Bohart (2000), however, notes that it is another thing for practice to be 
dictated by findings from clinical research.  
 Degree and attitudes.  Research revealed that licensed psychologists who hold a 
Psy.D. degree rate informing clients about alternative treatments and/or procedures 
(including no treatment) during the process of informed consent, as more important, than 
those who hold a Ph.D. degree.  The primary emphasis placed on a Psy.D. degree 
involves clinical practice and on training practitioners to be consumers of research. 
Research has substantiated the fact that, unlike the Ph.D. degree (Boulder-model) with an 
emphasis to produce research, the Vail-model Psy.D. programs provide slightly more 
clinical experience and clinical courses, but with less research experience (Tibbits-Kleber 
& Howell, 1987).  Although there appears to be little difference in employment 
opportunities, graduates from research-oriented Ph.D. programs are more likely to be 
employed in academic positions and in medical schools (Gaddy, Charlot-Swilley, Nelson, 
& Reich, 1995).  Thus it could be argued that psychologists with Psy.D. Degrees may be 
more likely to be practicing psychotherapists and have greater clinical exposure with 
informed consent procedures related to risks.  Those psychologists who hold Psy.D. 
Degrees may also have more experience in the clinical application of informed consent 
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related to addressing alternative treatments and/or procedures (including no treatment) 
during the informed consent process. 
Limitations and Implication for Future Research 
 Several limitations to the present study are apparent; this is evident with any 
research methodology.  First, the sample of licensed psychologists pooled belongs to the 
National Directory of Psychologists, the Association of Black Psychologists, and 
graduate school psychology programs listed on the APA directory.  Licensed 
psychologists with posted electronic mail addresses on these directories may possess 
unique characteristics which may affect their responses, in comparison with licensed 
psychologists who are not members of those websites and directories. 
 Another limitation involves the selection of subjects.  Licensed psychologists with 
electronic mail addresses posted on websites may possess unique characteristics which 
can limit generalizability to the entire population of psychologists.  Most of the 
participants were either in academic settings or in solo private practice (or both). 
Consequently, the selection of subjects may be a threat to external validity.  Furthermore, 
nearly all the participants were Caucasian, which may also limit how well the results 
represent the overall population of psychologists across the United States.  Another 
demographic characteristic that is considered a limitation is the type of degree, Ph.D. 
versus Psy.D. of the sample.  The majority holds a Ph.D.; therefore, they may have 
responded differently from psychologists who hold a Psy.D. or an Ed.D. Degree.   
 Also, the present study relied solely on self-report measures which are associated 
with a few major problems (Kazdin, 2003).  Respondents may distort their answers in a 
biased fashion because of the tendency toward giving socially desirable answers.  The 
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current study attempted to offset this limitation by including reassuring statements that 
the survey is completely anonymous and voluntary.  It is noteworthy that estimates of 
licensed psychologists’ attitudes, not their actual practices were assessed.  The attitudes 
obtained may represent upper estimates of the reality of addressing potential risk of 
negative treatment effects associated with psychotherapy.  Feedback from participants in 
the survey revealed they had difficulty rating only one modality of therapy (Question 24). 
It is also important to note that the sample consisted of licensed doctoral level 
psychologists and did not include those from other specialties.  Results were based on 
participants' attitudes and practices at the time of the measurement and because attitudes 
are dynamic, actual practices may vary considerably from self-reports or opinions 
(Croarkin et al. 2003).  The other problem that characterizes self-report measures is the 
lack of evidence that the questionnaire measures the construct of interest (Kazdin, 2003). 
This newly formed questionnaire is the only survey of its kind found in the literature.  
Therefore, comparisons could not be made with other research surveys regarding the 
constructs of interest.     
 More research is needed to gain insight into how licensed psychologists 
understand and practice addressing potential risk related to negative treatment effects 
associated with psychotherapy.  For example, it is unclear whether or not addressing 
negative treatment effects during informed consent affects how clients view treatment 
and subsequent outcome.  Further, there is extremely limited research that describes the 
practice of informed consent related to addressing risk of negative treatment effects. 
Addressing risk of negative treatment effects in the clinical context and its influence on 
psychotherapy outcome remains unknown.  Future research might investigate the impact 
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of addressing, early in the process of informed consent, potential risk of negative 
treatment effects and the implications on treatment outcome.  In addition, future research 
might investigate psychologists' attitudes toward informing clients of potentially negative 
effects with psychological assessment.  Although controversial, some projective tests 
(Rorschach inkblot test and Thematic Apperception Test) lack empirical support. 
Research has found that these tests are not invalid; however, the norms and decision rules 
tend to pathologize healthy individuals (Wood, Garb, Lilienfeld, & Nezworski, 2002).  In 
fact, Wood et al. (2002) reveal that 70 percent of pathology- free individuals will 
demonstrate serious disturbance on these measures.  Future research might investigate 
informed consent practices in the forensic setting, specifically, those regarding 
psychological evaluations and their potential to produce negative outcomes and life-
altering consequences. 
Conclusion 
 The apparent variability among licensed psychologists’ self-reported attitudes and 
practices, suggest that sole reliance on standards outlined in the Ethics Code (2002) might 
not be enough for clinical implementation regarding risk related to negative treatment 
effects associated with psychotherapy.  The informed consent process related to 
addressing potential risk of negative treatment effects must be tailored to the unique 
context of a particular psychotherapeutic treatment.  This study underscores the inherent 
complexity of applying ethical standards and principles to informed consent procedures 
related to risks of negative treatment effects as a result of engaging in psychotherapy. 
Although the phenomenon of risk, related to negative treatment effects appears 
convoluted, this survey study intended to both acknowledge the significance of the 
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problem and add to the limited body of research on practical applications of informed 
consent practice. 
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APPENDIX A 
(Electronic mail message sent for participant solicitation and recruitment purposes) 
Dear Volunteer/Doctor: 
My name is Neshe Sarkozy; I am a Doctoral Candidate in the APA accredited Clinical 
Psychology program at the Philadelphia College of Osteopathic Medicine (PCOM).  I 
am doing a survey research study on attitudes and practices of licensed psychologists 
related to the informed consent process.  By participating you may feel some personal 
satisfaction having taken part in research that may improve the ethical practice of 
informed consent implementation.  I would be grateful if you would complete the 
questionnaire at the following URL address:  
http://www.surveymonkey.com/s.aspx?sm=dSDV2FSbARlZFjKu6_2bB4lA_3d_3d 
Completion of the questionnaire is expected to take about 10 minutes. 
Participation in this project is voluntary and you are not asked any identifying 
information.  If you would like to take part in this survey study, please click NEXT at 
the beginning of the survey and it will automatically prompt you through to the 
questionnaire.  Should you have any comments or concerns resulting from your 
participation in this survey study, you can also contact PCOM’s Research Compliance 
Specialist at 215-871-6782.  Thank you for your time and interest in this research 
project. 
Respectfully, 
Neshe Sarkozy, M.A., M.S. Responsible Investigator 
Ginny Burks Salzer, Ph.D. Principal Investigator, Associate Professor  
Director of Clinical Psychology Research  
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APPENDIX B 
SURVEY QUESTIONNAIRE 
Dear Participant, 
All your responses will be kept confidential and you will not be identified in any way. 
You will be able to opt out of the survey at any time by simply exiting the survey.  
1) Are you licensed for independent practice as a psychologist? 
o Yes 
o No 
If you have answered YES, please complete the following survey. Thank you in advance.  
 
Instructions: For purposes of this study, client harm (negative effects) caused by some 
aspect of psychotherapy include; no change or benefit, excessive concern over worsening 
or new symptoms, excessive dependency on therapist, reluctance to seek future treatment, 
client abuse or misuse of psychotherapy, or physical harm.  
 
2) There are potential risks (negative effects) to clients engaging in psychotherapy. 
o Strongly Agree 
o Moderately Agree 
o Slightly Agree 
o Neutral 
o Slightly Disagree 
o Moderately Disagree 
o Strongly Disagree 
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3) How important is it to you to address potential negative effects of psychotherapy 
during the informed consent process? 
o Very Unimportant 
o Moderately Unimportant 
o Slightly Unimportant 
o Neutral 
o Slightly Important 
o Moderately Important 
o Very Important 
 
4) How important is it to you to inform clients of alternative treatment/procedures 
(including no treatment) during the informed consent process? 
o Very Unimportant 
o Moderately Unimportant 
o Slightly Unimportant 
o Neutral 
o Slightly Important 
o Moderately Important 
o Very Important 
 
 
 
INFORMED CONSENT IN PSYCHOTHERAPY 125 
5) At what point during the therapeutic process do you usually begin a discussion of 
informed consent? 
o Before the first session 
o During the first session 
o During the second session 
o During the third session 
o After the third session 
o On a “as needed” basis 
o Never 
 
6) What methods do you most commonly use to assess your patient/client's overall 
progress in therapy?  
o Questionnaires 
o Outcome measures/assessment 
o Asking the client 
o Giving and receiving feedback 
o None 
o Others: ____________ 
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7) Some psychotherapeutic treatment techniques produce a greater probability of 
potential negative effects than others. 
o Strongly Agree 
o Moderately Agree 
o Slightly Agree 
o Neutral 
o Slightly Disagree 
o Moderately Disagree 
o Strongly Disagree 
 
8) There are times when my judgment about a client prevents me from addressing 
negative effects of psychotherapy during the informed consent process. 
o Strongly Agree 
o Moderately Agree 
o Slightly Agree 
o Neutral 
o Slightly Disagree 
o Moderately Disagree 
o Strongly Disagree 
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9) My clients have reacted negatively during the informed consent process. 
o Strongly Agree 
o Moderately Agree 
o Slightly Agree 
o Neutral 
o Slightly Disagree 
o Moderately Disagree 
o Strongly Disagree 
 
10) Addressing potentially negative effects of psychotherapy during the informed consent 
process does not negatively impact the therapeutic alliance and subsequent treatment 
outcome. 
o Strongly Agree 
o Moderately Agree 
o Slightly Agree 
o Neutral 
o Slightly Disagree 
o Moderately Disagree 
o Strongly Disagree 
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11) During the informed consent process, a client’s current symptomology, personality, 
and overall functioning, impacts whether or not to address potential negative effects of 
engaging in psychotherapy. 
o Strongly Agree 
o Moderately Agree 
o Slightly Agree 
o Neutral 
o Slightly Disagree 
o Moderately Disagree 
o Strongly Disagree 
 
12) It is unethical to include a discussion of risk of potential negative effects of 
psychotherapy during the informed consent process: 
o Strongly Agree 
o Moderately Agree 
o Slightly Agree 
o Neutral 
o Slightly Disagree 
o Moderately Disagree 
o Strongly Disagree 
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13) At the onset of therapy, I always tell my clients not only that therapy might not work 
for them but they could become worse as a result of engaging in psychotherapy. 
o Strongly Agree 
o Moderately Agree 
o Slightly Agree 
o Neutral 
o Slightly Disagree 
o Moderately Disagree 
o Strongly Disagree 
 
14) Approximately 10 percent of clients get worse as a result of engaging in some aspect 
of psychotherapy? 
o Strongly Agree 
o Moderately Agree 
o Slightly Agree 
o Neutral 
o Slightly Disagree 
o Moderately Disagree 
o Strongly Disagree 
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Demographic Information: 
 
15) Gender:   
o Male 
o Female 
 
16) Year of Birth: (Scroll down option for ages 1935 - 1985) 
 
17) Ethnicity:   
o Caucasian 
o Black or African-American 
o Hispanic-American/Latino/a 
o Native-American/American Indian 
o Asian or Pacific Islander 
o Multiracial/Mixed 
o Other (please specify) 
 
18) Highest terminal degree completed:  
o Ph.D. 
o Psy.D. 
o Ed.D. 
o Other (please specify) 
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19) What is your Doctorate in? (Scroll down options) 
o Clinical 
o Counseling 
o Developmental 
o Experimental 
o Educational 
o Social 
o School  
o Industrial/organizational  
o Physiological 
o Environmental 
o Health 
o Family 
o Rehabilitation 
o Psychometrics and Quantitative 
o Forensic 
o Other (please specify) 
 
20) Are you American Board of Professional Psychology (ABPP) Certified? 
o Yes 
o No 
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21) What is your ABPP Certification Area(s)? 
o Behavioral 
o Clinical 
o Neuropsychology 
o Counseling 
o Family 
o Forensic 
o Group 
o Health 
o Psychoanalysis 
o Rehabilitation 
o School 
o Not certified by ABPP 
o Other (please specify) 
 
22) Number of years working as a psychologist of in a closely related field. 
o Less than 5 years 
o 5-10 years 
o 11-15 years 
o 16-20 years 
o 21-25 years 
o 26-30 years 
o More than 30 years 
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23) Population treated. (check all that apply) 
o Child 
o Adolescent 
o Adult 
o Older Adult 
 
24) Therapy modalities. (check all that apply) 
o Individual 
o Couple 
o Family 
o Group 
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25) Primary work setting/location. (check all that apply) 
o Hospital (public or private) 
o Partial hospitalization 
o Treatment facility (Drug and Alcohol, Residential Treatment, 
Rehabilitation) 
o Community Mental Health Center 
o Solo Independent Practice 
o Group Practice 
o Academia (College/University) 
o Research 
o Administration 
o School (public or private) 
o Managed care company 
o Correctional Facility 
o Retired 
o Other (please specify) 
 
 
 
 
 
 
 
INFORMED CONSENT IN PSYCHOTHERAPY 135 
26) Primary theoretical therapeutic orientation. 
o Behavioral 
o Cognitive-Behavioral 
o Existential/Humanistic 
o Psychodynamic 
o Social learning 
o Systems 
o Other (please specify) 
 
27) Have you ever attended a post-doctoral training on ethics that included information 
on the informed consent process? 
o Yes 
o No 
 
The End. Thank you for your participation.  
